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ABSTRACT 
 
Cunningham, Nancy, Ph.D., May 2007          IIP, Health Promotion & Anthropology 
 
An Assessment of the HIV Prevention Needs of Injection Drug Users in Montana 
 
Chairperson:  Dr. K. Ann Sondag 
 
  The purpose of this study was to assess HIV prevention needs of individuals living in 
Montana who use injection drugs (IDUs). Gaps between prevention needs and services 
were identified and recommendations for overcoming the barriers to accessing and 
implementing treatment needs and services were offered. 
  A qualitative case study approach was used. Data collection methods included: 1) IDU 
interviews, 2) Key Informant interviews, and 3) Documentation collection and archival 
record retrieval. 
  IDUs represented a wide range of demographic variables. While people of both genders, 
a variety of sexual orientations, ethnicities, educational levels, incomes and employment 
statuses participated in the interviews, none of these variables appeared to be a distinct 
indicator of increased HIV infection risk. Factors indicative of higher risk for infection 
included family dynamics, identifying with being a parent and having a purpose in life, 
social networks, and the type of drug used.  HIV prevention needs included substance 
abuse treatment; harm reduction services (clean syringes, educational outreach, free HIV 
and Hepatitis C testing, and social service organizations); and HIV prevention messages.  
Barriers to accessing and implementing services included lack of funding; prohibition or 
discouragement of services by state and federal laws; stigma and discrimination; and lack 
of agency networking.  Recommendations for closing gaps between needs and services 
included:  Ensure collaboration between agencies and HIV prevention services; Research 
options and formulate a plan for gaining access to clean syringes; Research options and 
formulate a plan for substance abuse treatment funding and Hepatitis C services; Ensure 
continued HIV prevention information dissemination through media campaigns and other 
educational interventions; and Ensure continued harm reduction services. 
  This study provides the Montana Department of Public Health and Human Services 
(DPHHS) valuable insight concerning HIV prevention needs for IDUs. Determining the 
needs of IDUs in Montana will ultimately improve the quality and availability of HIV 
prevention services, which in turn will improve the quality of life for IDUs and decrease 
or prevent the spread of HIV infection through injection drug use. 
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CHAPTER I 
INTRODUCTION TO THE STUDY  
The time of this writing marks the 25th year since Acquired Immunodeficiency 
Syndrome (AIDS) was first medically recognized.  AIDS is a global epidemic, and shows 
no sign of weakening its grip.  Its impact transcends geographic boundaries, gender 
differences, age, sexual preferences, religious beliefs, and social-economic status.   
Worldwide more than 25 million people have died of AIDS.  Counting both those who 
have died and those currently living with the Human Immunodeficiency Virus (HIV), 
more than 60 million people have been infected.  Daily an estimated 11,000 new 
infections occur and 8,000 people die from AIDS.  There is no cure.  Treatment advances 
have helped people live longer, however the cost and complexities of regiments put them 
out of reach for most (UNAIDS, 2006).   
In the United States, more than half a million people have died of AIDS.  To date, 
an estimated one million people are living with HIV, and incidence continues at a steady 
rate of 40,000 infections per year.  Although not everyone has access to care, more 
effective treatments have helped HIV+ people live longer.  Due to the reduction of HIV 
related deaths coupled with the continuing number of new HIV infections, HIV/AIDS 
prevalence is at its highest level ever, and continues to rise each year   Men who have sex 
with men (MSM) are still the largest population infected in this country, however HIV 
transmission for this population has decreased from 64% of total cases in 1985 to 42% in 
2004.  This reduction in infection rate can be attributed to effective HIV prevention 
programs for MSM.  In contrast, the number of cases due to injection drug use continues 
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at a steady rate.  Nearly one third of HIV cases are directly or indirectly related to 
injection drug use (UNAIDS, 2006).   
 There are an estimated 1.4 million injection drug users (IDUs) in North America.  
While drug injection use is directly related to HIV infection, sexual behaviors of IDUs 
and those who have sex with IDUs contribute indirectly to HIV incidence.  HIV 
transmission can occur among IDUs when injecting equipment is shared.  This includes 
injecting drugs with a “dirty” (previously used by another IDU) syringe, as well as 
sharing other injection paraphernalia such as water, cookers, cottons, and spoons, or drug 
preparations (Koester, Glanz and Baron, 2005).  In addition to sharing injecting 
equipment, HIV infection occurs among IDUs through unprotected sex.  High-risk drug 
use behaviors and high-risk sexual behaviors are often linked, increasing the risk of HIV 
infection (NIDA, 1999).   
 Nationwide, efforts for IDUs have centered on a comprehensive approach to 
prevent HIV transmission.  Several prevention strategies have shown positive results, and 
are most effective when they are combined and overlap.  Strategies include substance 
abuse treatment; community outreach; interventions to increase access to sterile syringes; 
interventions in the criminal justice system; strategies to prevent sexual transmission; 
counseling and testing; partner counseling and referral services; prevention case 
management; coordinated services for IDUs living with HIV/AIDS; and primary drug 
abuse prevention (NIDA, 1999). 
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In Montana approximately 24% of those who are HIV+ were infected by injection 
drug use (DPHHS, 2006) yet there is limited information about their HIV prevention 
needs.  For this reason it is important to identify the needs of this population in order to 
design interventions and services that can reduce the risk of transmission.  This study is 
the first comprehensive HIV prevention needs assessment targeting IDUs in Montana. 
Purpose of the Study 
 The purpose of this study was to assess the HIV prevention needs of individuals 
living in Montana who use injection drugs.  Gaps between prevention needs and existing 
services are identified and recommendations for overcoming the barriers to accessing and 
implementing HIV prevention treatment and services are offered. 
Significance of the Study 
 This study provides the Montana Department of Public Health and Human 
Services (DPHHS) and community based service providers working directly with IDUs 
in Montana valuable insight concerning their prevention needs.  Barriers to meeting 
needs were identified and gaps between needs and services are described.  Determining 
the needs of IDUs in Montana will ultimately improve the quality and availability of HIV 
prevention services, which in turn will improve the quality of life for IDUs and decrease 
or prevent the spread of HIV infection through injection drug use. 
Research Questions 
 The research questions examined in this study focus on the HIV prevention needs 
of IDUs.  They are as follows: 
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What are the HIV prevention needs of injection drug users in Montana? 
(a) What are the predisposing, reinforcing and enabling factors that influence the 
behaviors of IDUs that put them at risk for HIV infection?  
(b) What are the resource and service needs for IDUs? 
(c) What are the barriers to IDUs accessing prevention services? 
(d) What are the barriers to implementing HIV prevention services for IDUs? 
Delimitations 
The delimitations of the study are as follows: 
 1)  The study was delimited to individuals who are over the age of 18 living in       
      Montana who currently used or had used injection drugs in the past two years. 
 2)  Data was collected via IDU and Key Informant interviews, documentation       
      and archival records. 
 3)  Data collected from participants was restricted to self reports. 
 4)  The participants in this study were volunteers. 
 5)  Documentation and Archival Record retrieval was delimited to information           
      pertaining to Montana and published within the last five years. 
Limitations 
The limitations of the study were as follows: 
1) Data collected via interviews were limited to what the participants were 
willing and able to share. 
2)  Data collected were limited to the honesty and accuracy of the participants. 
3)  Data collected were limited to those individuals who were recruited by the       
     various sampling techniques. 
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4)  Documentation and Archival Record retrieval was limited to the information             
     the researcher was able to collect. 
5)  Data analyses were limited to the researcher's bias and ability to carry out          
     methodologies. 
Definition of Terms 
Acquired Immunodeficiency Syndrome (AIDS):  An HIV infected person receives a 
diagnosis of AIDS after developing a defined indicator illnesses or on the basis of a CD4 
Cell count of 200 or lower (CDC, Division of HIV/AIDS Prevention, 2005). 
High Risk Behaviors:  Engaging in the reuse or sharing of syringes, needles, and other 
drug injection equipment and engaging in unprotected sexual contact (NIDA, 2003). 
Human Immunodeficiency Virus (HIV):  The retrovirus isolated and recognized as 
causing or contributing to the cause of a disease agent of AIDS (CDC, 2005). 
Injection Drug User:  A person who uses a drug (e.g., heroin, cocaine, 
methamphetamine) administered with a needle and syringe (CDC, 2005). 
Key Informant:  Strategically placed individual who has knowledge and ability to report 
on the needs of those in the priority population, who may or may not be in a position of 
formal authority, but are often respected by others in the community and thus possess 
informal authority (McKenzie, Neiger & Smeltzer, 2005). 
Needle Exchange Program (NEP):  Programs that facilitate the exchange of used 
syringes for clean syringes in order to reduce the spread of blood borne infections 
(NIDA, 2003).
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CHAPTER II 
REVIEW OF LITERATURE  
 The purpose of this study was to assess the HIV prevention needs of individuals 
living in Montana who use injection drugs.  In this chapter a review of current literature 
on the HIV prevention needs of IDUs is presented along with a summary of the literature. 
In addition, specific research strategies for conducting needs assessments are addressed, 
and the PRECEDE model is discussed as a theoretical framework for assessing needs. 
Finally, the use of the literature review as a data collection and assessment tool is 
discussed. 
The Incidence and Prevalence of HIV/AIDS 
HIV/AIDS Worldwide and in the United States 
 UNAIDS/WHO published the latest statistics on the epidemic of HIV/AIDS in 
May 2006.  Globally, approximately five million people were infected in 2004, and more 
than three million died from the disease.  It is estimated that more than 40 million people 
are now living with HIV/AIDS worldwide (UNAIDS, 2006).  In the U.S., it is estimated 
that more than one million people are living with HIV, with almost a half million 
diagnosed with AIDS.  The Centers for Disease Control and Prevention (CDC) estimates 
40,000 people become infected with HIV, and 20,000 people die of AIDS related 
illnesses every year in the United States (CDC, 2006). 
HIV/AIDS in Montana 
As of September 30, 2006 The Montana Department of Health and Human 
Services (DPHHS) reported 730 HIV/AIDS cases in Montana. Of these cases, 283 
individuals have died, and 447 Montanans are currently living with HIV/AIDS.  It is 
 6
estimated, however, that approximately 25 % of those living with HIV are not aware of 
their positive status, which means that more than 600 Montanans are living with HIV.  
Fifteen to 20 Montanans are newly infected each year.  Approximately 24% of those 
infected were possibly exposed by injection drug use, similar to the national rate for this 
exposure category (DPHHS, 2006). 
Quality of Life Issues, Behaviors, and Other Factors that 
 Contribute to HIV Infection among IDUs 
Injection drug use is a major factor in HIV infection.  There are an estimated 1.4 
million IDUs in North America.  More than one-third of AIDS cases are directly or 
indirectly associated with injection drug use.  While drug injection practices are directly 
related to HIV infection, sexual behaviors of IDUs and those who have sex with IDUs 
contribute indirectly to these numbers. The context in which these behaviors are carried 
out also plays a part in the risk of HIV infection (NIDA, 2006). 
HIV transmission can occur among IDUs when injecting equipment is shared.  
This includes injecting drugs with a “dirty” (previously used by another IDU) syringe.  
One can also be infected when sharing other injection paraphernalia such as water, 
cookers, cottons, and spoons, or drug preparations (Koester, Glanz and Baron, 2005).  In 
addition to sharing injecting equipment, HIV infection occurs among IDUs through 
unprotected sex.  High-risk drug use behaviors and high-risk sexual behaviors are often 
linked, increasing the risk of HIV infection (NIDA, 1999).   
 The context in which IDUs engage in high risk behaviors is a determining factor 
in the degree of risk of HIV infection.  First, IDUs are often linked to tight social 
networks.  The size of the group, relationships among group members, social activities of 
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the group, types of drugs used and how they are used can influence the risk of HIV 
infection (Friedman et al., 1997).  When HIV is introduced into these networks, rapid 
transmission can occur.  Also, the geographic location of a network can also affect the 
risk of HIV infection.  Location influences types and quality of drugs available, social 
acceptance of certain types of drugs, and the method of drug administration (e.g., smoked 
vs. injected).  One study suggests the use of one type of heroin over another (“Mexican 
black tar” vs. powder only heroin) may help decrease HIV infection risk.  Because of its 
chemical properties, the Mexican black tar requires more rinsing of syringes to prevent 
clogging and more heating to enhance solubility.  These practices may reduce HIV from 
being transmitted if the paraphernalia is shared.  In addition, Mexican black tar can be 
injected subcutaneously or intramuscularly vs. venous injection, thus further reducing the 
risk of HIV infection.  Geographically, locations where Mexican black tar was prevalent 
had lower HIV prevalence than those with powder-only heroin (Ciccarone & Bourgois, 
2003).   
 Social status and income can affect HIV infection risk among IDUs.  Those who 
have a higher social status and a secure income, stable housing and supportive networks 
may be more able to control their risk of infection.  A federal decision to discontinue 
Supplemental Security Income (SSI) benefits to individuals who are addicted to alcohol 
or drugs is considered to be a contributing factor to their disability.  A 1999 study showed 
that IDUs who lost SSI benefits because of this law were more likely to engage in illegal 
activities, more likely to share syringes, and injected drugs more often than did IDUs who 
maintained benefits (Bluthenthal et al., 1999).     
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Strategies for HIV Prevention among IDUs 
 Addressing the HIV prevention needs of IDUs is challenging because it requires 
addressing complex public health problems – AIDS, substance abuse and addiction.  The 
complexity of the social, political and legal environments of these issues amplifies the 
difficulty of HIV prevention efforts.  Prevention providers, services agencies and 
community based organizations usually focus on only one aspect of the problem, such as 
substance abuse treatment, HIV prevention education, or harm reduction.   
While single methods have shown to be effective in preventing or reducing HIV 
infection, combining several interventions can increase the effectiveness of HIV 
prevention (Academy for Educational Development [AED], 2000).  The Centers for 
Disease Control and Prevention (CDC) now recommends addressing the prevention 
needs of IDUs using a comprehensive approach (2000).  Preventing Blood-born 
Infections Among Injection Drug Users: A Comprehensive Approach, is a document 
developed by AED under contract to CDC.  This model, created from a meta-analysis of 
more than 160 research articles and reports, focuses on eight research-based strategies 
supported by four foundational principles.  It was developed to be implemented across 
various settings, populations, life circumstances, patterns of drug use, and stages of 
behavior change (see illustration below).  The eight strategies include: 
• Substance abuse treatment; 
• Community outreach; 
• Interventions to increase access to sterile syringes; 
• Interventions in the criminal justice system; 
• Strategies to prevent sexual transmission; 
• Counseling and testing, partner counseling and referral services, and 
prevention case management; 
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• Coordinated services for IDUs living with HIV/AIDS; and 
• Primary drug prevention. 
These eight strategies are supported by four principles: 
• Ensuring coordination and collaboration of services; 
• Ensuring coverage, access and quality services; 
• Recognizing and overcome stigma; and  
• Tailoring services and programs to address specific needs of IDUs. 
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s 
  
Ensure Coverage, Access & Quality 
 
        (NIDA, 1999)  
 The following paragraphs detail each strategy and discuss the importance of 
integrating the four principles. 
Substance Abuse Treatment  
Studies have consistently shown that participation in substance abuse treatment 
contributes to lower drug injection practice, lower rates of other non-injection drug use, 
and a reduction of other risk behaviors related to HIV infection (Metzger & Navaline, 
2003; Sorenson & Copeland, 1999; Metzger, Navaline & Woody, 1998).  Substance 
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abuse treatment is an effective HIV prevention strategy.  IDUs who don’t receive 
treatment are up to six times more likely to become infected with HIV than those who 
enter and remain in treatment (NIDA, 2006).  Substance abuse treatment can provide 
medical, psychological and behavioral supports necessary to help individuals stop using 
drugs and to gain their health back.  Successful treatment can increase a person’s quality 
of life and decrease chronic conditions such as asthma, diabetes, high blood pressure and 
complications associated with abscesses.  Treatment can also improve family life, 
employment opportunities and decrease involvement with crime (NIDA, 1999). 
Community Outreach 
 Community outreach programs are effective in HIV prevention.  For IDUs, 
seeking out HIV prevention services may seem unimportant and abstract in comparison 
to the priorities of obtaining and using drugs.  Street outreach can bring services to IDUs 
who don’t access conventional services, and can provide services to IDUs in a familiar, 
safe setting. Community outreach can create a culture of risk reduction in the 
communities and social networks of IDUs, and has shown to decrease high risk behaviors 
(Wiebel et al., 1996).  Community outreach workers are often recovering IDUs 
themselves therefore services can be delivered by someone an IDU is more likely to trust.  
A 2004 study showed that drug users, after participating in a peer HIV prevention 
outreach program, were more likely to provide bleach to drug-using network members, 
more likely to report providing condoms to network members and more likely to engage 
in HIV prevention conversations.  In addition, HIV+ IDUs were more likely to report 
talking to sex partners and family members about HIV (Latkin, Hua & Davey, 2004). 
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Access to Sterile Syringes 
 Access to sterile syringes is a harm reduction method shown to be effective in 
reducing HIV infection (Huo, et al., 2005). It is the next best option in HIV prevention 
when abstaining from injecting drugs is not being practiced.  Interventions to provide 
access to sterile syringes include pharmacy sales of syringes and needle exchange 
programs (NEPs).  There are several barriers to accessing sterile syringes, despite the 
substantial research on the effectiveness of these interventions.  Most states restrict the 
sale, distribution and possession of sterile syringes and have criminal penalties for 
syringe possession.  Federal law prohibits supporting NEPs with federal funding.  Many 
organizations such as the American Medical Association (AMA), the National Alliance 
of State and Territorial AIDS Directors (NASTAD) and the American Pharmaceutical 
Association (APhA) have joined efforts urging state leaders in medicine, pharmacy and 
public heath to coordinate action to improve access to sterile syringes (NASTAD, 1999).  
There has been some controversy on whether NEPs encourage and increase drug 
injection practices however studies show that these programs do not cause an increase in 
injection drug use.  In fact, a reduction in HIV diagnoses reported among IDUs may be 
attributed to the use of NEPs (Taylor & Francis, 2006).     
Criminal Justice System Interventions 
 Injection drugs are illegal in the U.S., and many IDUs resort to criminal activity 
to support their drug addiction.  The United States has the largest number of incarcerated 
persons of any country in the western world.  More than one quarter of inmates in the 
U.S. are arrested for drug-related offenses including using, possessing or trafficking 
drugs (USDOJ, 2006).  Inmates are at high risk for HIV, hepatitis and other sexually 
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transmitted infections, and many are already infected.  Incarcerated individuals have an 
HIV/AIDS diagnosis rate six times higher than the national population (CDC, 2006).  
HIV prevention efforts are imperative in the criminal justice system, as high-risk sexual 
activity, sharing injection equipment and tattooing are prevalent behaviors in correctional 
facilities.  Prevention services and education programs can decrease HIV infection among 
inmates (NIDA, 2006).  In addition, correctional facilities can provide an opportunity for 
IDUs to access basic health care, substance abuse treatment, and HIV counseling and 
testing.  However correctional facilities are maintained by different federal, state and 
local entities, and services provided widely vary from site to site.  Also, correctional 
facilities’ primary purpose is to maintain security over the incarcerated.  Because of this, 
other services become less of a priority therefore not all inmates receive the same quality 
service, if at all.  One study showed that although 800,000 inmates could have benefited 
from substance abuse treatment, fewer than 20% actually received it (Epstein & Gfoerer, 
1998). 
Sexual Transmission Prevention 
 Sexual transmission prevention cannot be overlooked for the IDU population.  
High-risk sexual behaviors are often linked to high-risk drug behaviors, including having 
unprotected sex and an increased number of sex partners.  In addition, some IDUs will 
exchange sex for drugs or money.  Interventions specific to IDUs should include 
information and education on preventing HIV infection through sexual practices (NIDA, 
1999).  
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Counseling and Testing, Partner Counseling and Referral Services, and Prevention 
Case Management 
 HIV testing is integral to HIV prevention, treatment and care efforts.   Knowing 
one’s HIV status is important for preventing the spread of the disease.  Studies have 
shown that those who learn they are HIV+ reduce their high risk behaviors for HIV 
transmission (Marks et al., 2005; CDC, 2003).  Early knowledge of HIV infection can get 
a person into medical care and services earlier, which in turn can reduce health problems 
and improve quality of life.  When an individual seeks out testing services, a one-on-one 
opportunity arises to address high risk behaviors and other complex life circumstances 
that influence HIV infection risk.  If an individual tests positive, partner counseling and 
referral services can help notify sex and drug sharing partners so that HIV infection is 
slowed or stopped within their social network.  In addition, prevention case management 
can be very beneficial to high risk individuals to address HIV risk and other issues such 
substance abuse, mental health problems, and social and cultural factors (NIDA, 1999). 
Services for IDUs Living With HIV/AIDS 
 Services for IDUs living with HIV/AIDS are crucial to HIV prevention efforts.  
Many IDUs continue to engage in high risk behaviors in spite of their HIV status 
(Riehman, et al., 2004).  Many times, obtaining and using drugs takes priority over HIV 
prevention.  Unlike non-IDUs, many IDUs are less likely to access HIV/AIDS services 
because of the stigmatized “double whammy” of being HIV+ and an IDU (Reidpath & 
Chan, 2005).  Negative attitudes toward IDUs can only exacerbate barriers to care.  When 
an IDU enters care for their HIV, other issues such as substance abuse, mental health and 
quality of life can be addressed (NIDA, 1999). 
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Primary Drug Prevention 
 Primary drug prevention plays a key role in HIV prevention.  Avoiding drug use 
and drug injection altogether eliminates many risks associated with HIV infection.  
Primary prevention interventions can be conducted in many different settings such as 
schools and community-based organizations, and primary prevention messages can be 
conveyed through different forms of media such as television and radio.  Primary drug 
prevention interventions aimed at youth help delay substance use and may prevent many 
other problems such as academic issues, violence, suicides and risky sexual behaviors 
associated with drug use during the adolescent years (NIDA, 1999).   
Four Principles of a Comprehensive Approach 
 The eight strategies in CDC’s comprehensive approach to HIV prevention are 
supported by four principles: Ensure coordination and collaboration; ensure coverage, 
access and quality; recognize and overcome stigma; and tailor services and programs.  
Incorporating these principles into HIV prevention efforts can build a stronger overall 
program to help prevent or reduce the spread of HIV.   
 Agencies and providers must work together in order for HIV prevention 
interventions to be successful.  Different approaches and philosophies of HIV prevention 
among providers can be challenging, but they need to be set aside to achieve the larger 
goals of reducing HIV infection.  In addition, ensuring that high-quality programs are 
accessible to IDUs and that they are actually reaching IDUs is vital to a successful 
program (AED, 1999). 
 There are many negative attitudes, stereotypes, and stigma attached to injecting 
drug users and their addiction.  IDUs are sometimes dehumanized.  To put a human face 
 15
on the problems and to understand the disease of drug addiction can help overcome the 
stigma attached to substance abuse.  Stigma related to HIV also produces discrimination 
among IDUs, and has proven to be perhaps the most difficult obstacles in effective HIV 
prevention.  Stigma may prevent individuals from negotiating safer sex, taking an HIV 
test, disclosing their status to partners and seeking treatment (UNAIDS, 2006).  
Recognizing and overcoming these barriers is crucial to HIV prevention success. 
 Tailoring services and programs to fit specific IDU needs is important in HIV 
prevention.  IDUs have unique languages, cultures, life circumstances, and social 
supports.  Taking these considerations into account can improve the overall quality and 
effectiveness of services and programs.  Involving IDUs in planning, implementing and 
evaluating services will ensure that they are appropriately tailored (AED, 1999). 
Summary of Literature 
 Quality of life issues such as homelessness, social stigma and tight social 
networks can encourage behaviors that contribute to the spread of HIV infection.  
Behaviors such as the sharing of needles and other injection equipment and unsafe sexual 
practices put IDUs at risk for infection.  There are multiple factors that contribute to this 
high risk behavior.  Some of the factors identified in this literature review include 
knowledge about the risk of HIV infection associated with high risk behaviors and access 
to sterile syringes and other health related services.  Substance addiction in and of itself 
contributes to high risk behaviors.  The geographic location of a network can also affect 
the risk of HIV infection.  Location influences types and quality of drugs available, social 
acceptance of certain types of drugs, and the method of drug administration. 
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A review of policy and resources that contribute to HIV infection among IDUs 
reveals a lack of financial resources for primary prevention and treatment.  Fragmented 
services contribute to IDUs not accessing or not even knowing what services are 
available to help them remain HIV free.  Government policies that restrict needle 
exchange create barriers to accessing sterile syringes.  Criminal penalties for drug or 
paraphernalia possession, the use of illegal drugs or selling/distributing drugs contributes 
to the “underground” IDU culture. 
Strategies for Conducting Needs Assessments 
 Assessing the needs of a target population is the first step in Health Promotion 
programming.  Several research methods can be used to conduct a needs assessment.   
A common method that has been used in the public health, substance abuse and 
HIV/AIDS fields is Rapid Assessment and Response (RAR).  RAR has been used to 
understand public health problems so that appropriate interventions can be rapidly 
implemented.  Organizations such as the World Health Organization (WHO), the Joint 
United Nations Programme on HIV/AIDS and the U.S. Office of HIV/AIDS Policy have 
issued guidelines for conducting RARs (Stimson, Fitch and Rhodes, 1998).  These 
guidelines have been used to conduct several RARs worldwide on injection drug use and 
HIV transmission.  For example, a RAR focusing on HIV prevention needs of IDUs was 
conducted in the Russian Federation in 1999 when HIV incidence increased rapidly and 
speedy intervention implementation was necessary (Burrows, Trotter, Singer, et al., 
1999).  In the United States RAR methods have been used to identify HIV prevention 
needs among African American and Hispanic communities (Needle, Trotter, Singer, et al, 
2003).  Although RARs focusing on HIV and substance use issues have been conducted 
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in more than 70 countries, most rapid assessment guides and reports are unpublished 
(Fitch & Stimson, 2003).  RAR is used for more practical purposes, and when 
conventional social science research methods are inappropriate for the situation at hand.  
Some critics would argue that RARs are “watered down’ and inadequate to be considered 
as true research (Fitch, Rhodes, et al, 2003).  This may explain the lack of information in 
the research literature on HIV needs assessments.  A study conducted by the WHO 
however did indicate that RARs appear to be effective in linking assessment to 
development of appropriate interventions (Stimson, Fitch, Jarlais, et al., 2006). 
While RAR has been a common assessment process used in HIV prevention, the 
case study is another research methodology that can be used to identify the needs of a 
target population.  RAR and the case study designs are very similar.  Both methods rely 
on multiple sources of evidence and data analysis using triangulation; both methods are 
exploratory in nature, and answer the questions “what “ or “how”; both methods can 
investigate a situation in which variables may not be well defined; and both methods 
require the research to take place in its real-life context  (Yin, 2003).  Specific differences 
between the two methods define the rationale for their use.  RAR is conducted quickly, 
usually over a period of just days to less than six weeks.  RAR is appropriate when time 
is of the essence and immediate action is necessary.  Also, more than one researcher is 
always involved in RAR.  This allows data collection to occur simultaneously at different 
locations, perhaps when a large geographical area needs to be covered in a timely 
fashion.  The case study, on the other hand, involves a more structured research design.  
The case study specifies the logic of design, data collection techniques, and approaches to 
data analysis.  Also, validity and reliability can be more easily established and controlled 
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in a strong case study design; a well-conducted case study has the possibility to be 
replicated (Yin, 2003).  For these reasons, the case study design was used to conduct this 
needs assessment to identify the HIV prevention needs of IDUs living in Montana. 
The PRECEDE Model 
 The PRECEDE-PROCEED Model is the most widely used model in Health 
Promotion programming.  This theoretical framework provides an approach to 
identifying a target population’s needs. The PRECEDE Model “takes into account the 
multiple factors that shape health status and helps the planner arrive at a highly focused 
subset of those factors as targets for intervention.  PRECEDE also generates specific 
objectives and criteria for evaluation” (McKenzie, Neiger & Smeltzer, 2005).  The five 
phases of the PRECEDE Model include the following:  
1)  Social Assessment (identifying quality of life issues) 
2)  Epidemiological Assessment (identifying health problems that arise from or          
     contribute to the issues identified in phase 1)  
3)  Behavioral and Environmental Assessment (identifying behavioral issues that  
     contribute to health problems such as compliance, coping, self-care, etc.; as    
     well as environmental issues such as access to services, stigma, etc.)   
4)  Educational Assessment (identifying predisposing, reinforcing and enabling        
    factors that influence a given behavior) 
5)  Administrative and Policy Assessment (identifying policies and resources that 
could hinder or facilitate the development of programs). 
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 The phases of the PRECEDE model were used as a guide for conducting a 
literature review of the HIV prevention needs of IDUs.  In addition, phases four and five 
aided in formulating the research questions for this study. 
The Use of Literature Review as a Data Collection and Assessment Tool 
 While it is common practice for researchers using quantitative methodologies to 
conduct a comprehensive review of the literature prior to collecting data, it not always a 
common practice for the qualitative researcher.  In fact, qualitative researchers often must 
determine how the literature can be used to enhance, rather than constrain, the process of 
development of concepts and theories.  The researcher does not want to be so steeped in 
literature that he or she feels constrained or even stifled by it (Anslem and Strauss, 1998).  
There are, however, multiple ways that the literature can be used to enhance qualitative 
research.  For the purposes of this study, the literature review served two functions.  First, 
information obtained from the literature review aided in the development of theoretical 
propositions to guide data collection and analysis.  Also, concepts derived from the 
literature provided a source for making comparisons at the dimensional level.  In other 
words, concepts from the researcher’s data were compared to those from the literature 
and used to support and give specificity to emergent themes (triangulation).  Second, the 
literature was used as a secondary source of data.  Information from research publications 
was used as data and analyzed using the methods described in Chapter Three.   
When primary data collection for this study was complete, the literature was used 
to either confirm the findings or to illustrate where the literature seems incorrect or 
incomplete.  Bringing the literature into the writing of the final report for this study 
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allowed for extending, validating and refining the knowledge that currently exists in the 
field. 
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CHAPTER III 
METHODOLOGY 
 A qualitative case study approach was used to determine the HIV prevention 
needs of individuals living in Montana who use injection drugs. 
Description of Target Population 
 The target population was male and female individuals over the age of 18 living 
in the state of Montana who currently used or had used injection drugs in the past two 
years.  For the purpose of this study, an IDU was defined as a person who uses a drug 
administered with a needle and syringe (CDC, 2005).   
Protection of Human Subjects 
 The human subject application material and consent forms were completed in 
accordance with The University of Montana Institutional Review Board (IRB) (see 
Appendix A). 
Research Design 
 The structure of this case study was guided by the exploratory, embedded, single-
case design.  Case study is used to identify knowledge of individual, group, 
organizational, social, political and related phenomena.  It is a common research 
methodology in community planning to understand complex social occurrences (Yin, 
2003).  As defined by Yin (2003), a case study is “an empirical inquiry that investigates a 
contemporary phenomenon within its real-life context, especially when the boundaries 
between phenomenon and context are not clearly evident” (p. 13).  Because phenomenon 
and context are not always noticeable in real-life situations, the case study deals with the 
technically unique situation in which there are many more variables of interest than 
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identified data points.  As a result, this method relies on multiple sources of evidence and 
data analysis using triangulation, and benefits from the prior development of theoretical 
propositions to guide data collection and analysis.  Hence, the case study is an all-
encompassing method, covering the logic of research design, data collection methods, 
and specific approaches to data analysis (Yin, 2003).   
This case study is an exploratory, embedded single-case design.  Multiple sources 
of data were used to explore the HIV prevention needs of IDUs in Montana. The 
following figure depicts this particular design. 
Embedded, Single-Case Design (Yin, 2003) 
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Procedures 
Instrumentation, Nature of Selected Sample, and Data Collection 
 Data was collected using three methods: 1) IDU interviews, 2) Key Informant 
interviews, and 3) Documentation collection and archival record retrieval.  The 
instrumentation, sample and data collection techniques for each method are described 
below. 
 IDU Participant Interviews 
Instrumentation.  An interview question schedule was developed using the 
PRECEED-PROCEDE model for health program planning (see Appendix B).  The 
instrument was reviewed and revised by an expert panel, and pilot tested by members of 
the target population.   
 Nature of selected sample.  IDU interview participants were recruited using four 
different methods:   
1) Individuals who conduct HIV testing at sites funded by DPHHS were asked to provide 
IDU clients with a business card that included a phone number and an invitation to call 
that number to set up an interview;   
2) Montana Targeted Outreach Project (MTAP)* IDU outreach workers distributed the 
same business cards to IDU contacts; 
3) The snowball technique was used to assure that individuals who were not in contact 
with MTAP outreach workers and who have not gone in for an HIV test were included in 
the sample.  The technique involved the recruitment of interview participants by asking  
* Montana Targeted Outreach Program (MTAP) is a CDC funded street and community outreach project 
working to stop the spread of HIV and Hepatitis C (HCV) throughout Montana.  MTAP works in 
collaboration with eight local community based organizations and tribal agencies to disseminate HIV and 
HCV prevention, offer rapid HIV counseling and testing, and conduct agency referrals.  
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interviewees to give the contact business card to other IDUs in their social network; and 
4) Key informants were asked to distribute the same business card to contacts.   
 IDUs who wished to volunteer for an interview contacted the researcher via the 
private phone number found on the business card.  A $30.00 cash incentive was offered 
to all interviewees. 
 Data Collection.  When an individual contacted the researcher via telephone, 
arrangements were made to conduct the interview in a convenient and private place.  
Before the interview, the participant was asked to read a modified consent form and 
verbally give consent (Appendix A).  Once verbal consent was obtained, a $30.00 cash 
incentive was given to the participant before the interview began.  In addition, 
participants were offered the interview question schedule prior to the interview.  The 
researcher conducted the interview, and when the participant agreed, it was audio taped.  
The researcher also took written notes as determined necessary.  The number of 
interviews was determined based upon the comparative method of data analysis 
(Creswell, 1998) (see Data Analysis section below). 
 Key Informant Interviews 
 Instrumentation.  An interview question schedule was developed using the 
PRECEED-PROCEDE model for health program planning (see Appendix C).  The 
instrument was reviewed and revised by an expert panel, and pilot tested by members of 
the target population.   
 Nature of selected sample.  Key informant interviews were conducted with 
professionals who offer services to IDUs.  Indigenous leaders/gate keepers recommended 
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individuals who they believe would be able to provide the best information regarding the 
needs of IDUs in Montana.   
 Data Collection.  Key Informants were asked to sign a consent form (Appendix 
A) and offered a list of the interview questions prior to the interview.  Interviews were 
conducted one of three ways by the researcher: 
1)  The interview was conducted face to face.  The researcher took written notes as 
determined necessary;  
2)  The interview was conducted via the telephone.  The researcher took written notes as 
determined as necessary. 
3)  The interview schedule along with a consent form was given to the Key Informant in 
person or sent to the key informant either by postal mail, fax or electronic mail.  The key 
informant completed the interview questions with written answers, and returned the 
questionnaire to the researcher. 
The number of interviews was determined based upon the comparative method of 
data analysis (Creswell, 1998) (see Data Analysis section below). 
 Documentation and Archival Records 
 Collecting documentation is a customary research method in the case study 
design.  Documentary information and archival records were used to corroborate and 
augment evidence, and to make inferences regarding IDUs.  Inferences generated 
additional clues to investigate, and provided richer data relevant to the needs of IDUs in 
Montana.  Information was collected from various types of documents and archival 
records including: 
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• Administrative documents such as meeting minutes, written reports; 
• Other HIV-related evaluations conducted in Montana; 
• Newspaper clippings and other articles appearing in mass media or 
community newsletters specific to Montana; 
• Internet websites containing information specific to Montana populations 
at high risk for HIV; 
• Service and organizational records, such as number and type of clients 
served, etc.; 
• Maps and charts of geographical characteristics or layouts relating to HIV, 
such as epidemiology, populations affected, etc.; 
• Survey data, such as census records or other data previously collected. 
 
 The following chart presents a description of the data sources and their 
contribution to answering the research questions of this study.  
  Interviews 
with IDUs 
Interviews with 
Key Informants 
Documentation & 
Archival Records 
What are the factors that 
contribute to the behaviors 
of IDUs? 
 
 
X 
 
 
X 
 
 
 
  What are the assistance 
and/or treatment service 
needs for IDUs? 
 
   
X X X 
What are the barriers to 
IDUs accessing prevention 
service needs? 
  
X 
 
X X 
What are the barriers to 
implementing HIV 
prevention service needs 
for IDUS? 
  
X 
 
X 
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Data Analysis 
Qualitative Data Analysis 
 Data collected for this study came from IDU interviews, key informant 
interviews, and documentation and archival record retrieval.  The identities of IDUs and 
Key Informants who participated in the interviews remain anonymous.  No names or 
other identifying information are reported as part of the data analysis.  All data is reported 
as group data.   
 IDU and Key Informant Interviews 
  Protocol for data analysis was followed as suggested by Creswell (1998).  
Immediately following the interview sessions, the researcher reviewed notes and the 
tapes.  A contact summary sheet was used to record general impressions of the interview 
process including length of interview, location, general description of the interviewee, 
and any notable or unusual circumstances (see Appendix D).  IDU interview tapes were 
transcribed completely and compared to the notes to check for accuracy.   
 The transcriptions were qualitatively analyzed for the existence of matching 
patterns and common themes using the constant comparative method of data analysis 
(Creswell, 1998).  Transcriptions were analyzed as the interviews were conducted, rather 
than waiting until a certain number of interviews were completed.  This method of data 
analysis allowed for matching patterns and themes to build upon one another as new data 
were continually compared to already-analyzed data.  Each transcription was read 
numerous times, and notes were taken in margins of the transcriptions.  As general 
themes and matching patterns emerged, each were color coded for tracking purposes.  
Matching patterns and emergent themes and concepts were organized into categories.  In 
 28
addition, unusual and/or other significant information were identified.  Interviews 
continued to be conducted until the data showed saturation.  Saturation occurred when no 
new information seemed to emerge as a result of coding additional interviews. 
 Documentation and Archival Records  
 Documents and archival records were reviewed and analyzed for supporting 
interview data.  As each document was reviewed, important information was recorded 
and categorized according to identified patterns and themes from the participant and key 
informant interviews.  In addition, any outlying themes or emerging patterns were noted.   
Convergence of Evidence 
 A case study database was created from all data collected, using the basis of the 
study research questions.  All information was organized using these propositions to 
support the case study design.  Triangulation of data was conducted.  Converging lines of 
inquiry were developed from all data sources (see diagram below).   
Convergence of Evidence 
     
     Documents              IDU interviews 
    
   
 Facts  
Conclusions  
  
 
     Archival Records                Key Informant interviews 
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Construct Validity and Reliability 
 Two strategies were used to control for construct validity.  First, multiple sources 
of evidence (triangulation) were used.  That is, each piece of information gained, or each 
conclusion reached was considered tentative until it has been corroborated by information 
collected by other means or from other sources.  This triangulation of the data served to 
increase construct validity.  Second, a draft case study report was reviewed by key 
informants to enable the researcher to cross-check her constructs with those of the 
participants.  And finally, to control for reliability, a “chain of evidence” was established 
during data collection.  In other words, the researcher provided a clear description of 
what questions were under investigation, which data sources were used and how the 
situation and persons studied were defined.  This permits a second researcher to follow 
the same steps, so that the case study methodology may be replicated (Yin, 2003). 
Final Report 
Data from all sources were synthesized into a key findings report and submitted to 
DPHHS.  The report includes:  Introduction, Purpose of the Assessment Project, 
Methods, Results, Conclusions, Recommendations and References.   This report can be 
used as a tool for DPHHS, HIV prevention specialists, health service providers and HIV 
program directors to adapt their programs to insure that they are meeting the needs of 
IDUs in Montana, and HIV infection among IDUs can be minimized.
 30
CHAPTER IV 
RESULTS 
 The purpose of this study was to assess the HIV prevention needs of individuals 
living in Montana who use injection drugs.  The barriers to accessing and implementing  
HIV/AIDS prevention assistance and/or treatment were also identified.  Data was 
collected from the following sources: 1) IDU interviews, 2) Key Informant interviews, 
and 3) Documentation collection and archival record retrieval.  The results for each data 
source are organized into the following sections:  
1. Description of the Study Sample 
 
2.   Themes Related to Research Questions 
 
• What are the predisposing, reinforcing and enabling factors that influence 
the behaviors of IDUs that put them at risk for HIV infection?  
• What are the resource and/or service needs of IDUs? 
• What are the barriers to IDUs accessing prevention services? 
• What are the barriers to implementing HIV prevention services and 
programs for IDUs? 
A chart that summarizes all of the results is included at the end of this chapter. 
IDU Participant Interview Results 
 A total of 20 IDU Participant interviews were conducted. The researcher 
conducted all interviews face to face.  Fifteen of the twenty interviews were recorded and 
transcribed.  Five of the participants asked that their interview not be audio recorded. 
Transcriptions were read and re-read, and color-coded for emerging themes (see Chapter 
Three, Data Analysis).  
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Section 1:  Description of the Study Sample  
 The following tables describe basic demographics and high risk behaviors of IDU 
participants. 
Table 1.  IDU Participant Demographics Summary 
N=20 
Age • Age ranged from 19 to 48 years old 
• Average age was 32 years old 
Gender • 50% (10) were female 
• 50% (10) were male 
Ethnicity • 75% (15) identified as white 
• 25% (5) identified as Native American 
Sexual 
Orientation 
• 80% (16) identified as heterosexual 
• 10% (2) identified as MSM 
• 10% (2) identified as lesbian 
Education • 25% (5) reported having some high school education 
• 30% (6) reported completing a G.E.D. 
• 20% (4) reported receiving a High School Diploma 
• 25% (5) had completed a G.E.D. or high school and some 
college 
Location of 
Residence 
(Refer to 
Appendix E for 
Regional Map of 
Montana) 
• 15% (3) reported living in Region 1 
• 5% (1) reported living in Region 3 
• 10% (2) reported living in Region 4 
• 60% (12) reported living in Region 5 
• 2 in northern; 8 in central; 2 in southern;  
• 10% (2) reported just traveling through Montana 
 
• 85% (17) reported sometimes traveling and living outside of 
Montana. Other places of "residence" included: 
• Seattle, Spokane and other communities is WA 
• Portland and Eugene Oregon 
• San Francisco, San Diego, LA and other northern CA 
communities 
• New York City, Miami and Chicago 
• Minnesota 
• Florida 
• Texas 
Employment and 
Type of Work 
Preferred 
 
• 35% (7) reported being currently employed 
• 60% (12) were not working at the time of interview 
• 5% (1) was on disability 
• Type of work reported included (includes type of work 
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preferred for those who were currently not working): 
• Personal Care Assistant 
• Carpentry/painting/construction 
• Cooking/restaurant work 
• Stay at home mom 
• Receptionist 
• Bartender 
• Computer programming 
• Customer service/telemarketing 
HIV Status • 10% (2) reported being HIV positive 
• 80% (16) reported being HIV negative with last HIV test; 8 
were retested with no positive results; 
• 10% (2) reported not knowing their HIV status; both were tested 
with no positive results 
Hepatitis C Status • 60% (12) reported being Hepatitis C positive 
• 20% (4) reported being Hepatitis C negative 
• 20% (4) reported not knowing their Hepatitis C status 
Family Dynamics • All participants came from alcoholic and/or drug using families 
HIV and  • All participants were knowledgeable about HIV transmission, 
and knew that needle/works sharing and unprotected sex were 
risky behaviors.   
Hepatitis C 
Knowledge 
 • Unprotected sex was viewed as less risky for HIV infection than 
needle/works sharing.   
• All participants were aware and knowledgeable about Hepatitis 
C, as well.  Many reported learning more about HIV after they 
learned about their positive status for Hepatitis C. 
• Participants reported learning about HIV on the street, in jail, in 
treatment, at needle exchange programs and in school.  School 
education about HIV correlated with the participant's age; the 
younger the participant the more apt they were to have received 
HIV education in a school setting. 
Age at First Use of 
Any Substance, 
Age of First 
Injection and 
Number of Years 
Injecting. 
• Age at first use of any substance ranged from 3 to 16; average 
age was 11 years old.   
• Age of first injection ranged from 15 to 38; average age was 21 
years old.  
• Number of years an IDU had been injecting ranged from one to 
31 years, with an average of 9.5 years. 
Current Drug Use • 15% (3) reported being "clean", indicating that they were not 
currently injecting (does not include alcohol or other drug use) 
• 85% (17) reported currently injecting 
• Time from last injection ranged from "today" to two months 
ago. 
• All participants said that they would choose to inject their drug 
of choice, but also reported smoking, snorting, ingesting and 
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"booty bumping" (inserting meth into the rectum). 
Drug of Choice 
 
• 50% (10) reported some type of amphetamine (meth, speed, 
coke) as their injected drug of choice 
• 25% (5) reported heroin or other opiates as their injected drug 
of choice 
• 25% (5) reported a combination of amphetamine and opiate as 
their injected drug of choice.  
Substance 
Use/Abuse 
Treatment 
• 45% (9) reported receiving no treatment 
• 50% (10) reported receiving court ordered treatment 
• 5% (1) was self referred to treatment  
 
 
 
 
Table 2. IDU Participant High Risk Behavior Summary 
N=20 
Sharing 
Needles/Works 
• All but two participants reported sharing needles.   
• Every participant reported being aware of HIV infection risk at 
the time of sharing. Reasons for sharing included: 
• Had only the option of sharing or not get high; 
• Only sharing with people they knew or people they 
trusted; 
• Using the needle first before anyone else; 
• Rinsed or bleached in between shots; and 
• Asked the person if they had HIV and trusted their 
answer. 
Unprotected Sex • All participants had reported in engaging in unprotected sex. 
• This behavior was viewed as a lesser risk than needle/works 
sharing for HIV infection.  
• For female participants, getting pregnant or being taken 
advantage of sexually was more of a concern than HIV 
infection.  
• They reported that when they engaged in sex and were also 
under the influence of drugs that these issues became even less 
of a priority. 
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Section 2:  Emerging Themes Related to Research Questions 
 Research Question:  What are the Predisposing, Reinforcing and Enabling 
Factors that Influence High Risk Behaviors? 
Theme #1:  Substance Use/Abuse 
 Sub-theme #1:  Type of Drug Used and Social Perception (Enabling). 
 Identifying oneself as an IDU, as well as identifying with their drug of choice was 
a way for an IDU to justify engaging in the high risk behavior of injecting. The needle 
appeared to be just one part of their persona.  Those who chose methamphetamine as 
their primary drug of choice tended to view opiate users as "junkies" and crack cocaine 
users as dirty or unclean.  In contrast, opiate users tended to view meth or crack users as 
"tweakers" and viewed them as violent and a social problem.  Those who identified both 
amphetamine and opiates as drugs of choice, tended to view themselves as mere drug 
addicts, simply needing to get high. In spite of what perception an IDU had of other drug 
users because of the drug they chose, most participants had used both amphetamines and 
opiates but self-identified with one drug over another, and in their view regarded their 
drug superior to the others. This perception connected them to an attitude that made it 
"better" and justified engaging in high risk behaviors as part of their lifestyle. 
Supporting quotes: 
• “I don’t like tweakers man. And a crack head, he just wants five dollars for his next 
hit in 20 minutes, and a junkie just needs 10 bucks so he can stay high all night. A 
tweaker might think you’re a cop, might think you stole his dope, who knows what 
the dude’s thinking after he’s been up for two weeks. You know what I mean. You 
know you can’t trust a tweaker at all.” 
 
•  “I am very adamant about the fact that I’m not a junkie, I’m a banger.  In my 
opinion, there is a big difference. A banger is better. My mother hates my boyfriend 
because she doesn’t know that we’re using, she thinks he’s just the biggest junkie in 
the world, because he uses needles. She uses pills, but he’s a loser.” 
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• “I’ve seen a dirty crack head, but that’s not a meth head. We’re clean people. I 
mean I know bangers who have been doing it for a long, long time, like twice my 
age and I never seen anybody get that bad. It’s just bullshit, it’s a lot of bullshit 
‘cuz you know what, it  [the Meth Project] makes people look more down on it, 
because like,  you’re going to look like that, no you don’t . Me, personally, no. I get 
high, my house is spotless, everything is in order.” 
 
• “I consider opiates my drug of choice. Yea, I’ll do ritalins, adderall, meth, 
whatever. But I don’t like the speeds ‘cuz the people.  I will admit that I’m a drug 
abuser but I feel like I have a reason for doing it.  And I’m not doctor shopping, I 
just want to take care of myself. You gotta be careful, and this town is a dangerous 
town for buying drugs in so I try to avoid doing it and it’s really really expensive.  
Speed is a bing constantly, 30, 40, 60 bucks and I was in the big city where those 
people were buzzing all over the place. When you’re up for a week and a half you’ll 
be living in a dumpster in a broke house. That’s why I don’t want to get involved 
with those people because I can’t deal with them.” 
 
• “I don’t like crack, but I did it recently in Spokane, and it was like wow I like this 
way too much, you know. I seen so many crack heads, the lifestyle is the most 
saddening to me, to see what they do. This one guy lets guys suck him off for ten, 
five bucks to buy a rock. It really bothers me. I personally can’t understand how 
one could get to that point” (This is a participant that almost died the night before 
she came in for the interview, and has no real recollection on what her behavior 
was before she overdosed).  
 
 Sub-theme #2:  Readiness to Change Behavior (Predisposing). 
 The main factor associated with decreasing or discontinuing substance use/abuse 
was the readiness to engage in this behavior.  Every participant commented on the fact 
that “you’re not ready until you’re ready.” Ten participants had been court ordered to 
treatment, and none of them were yet clean.  The view of court ordered treatment is that 
is does not work.  They did however think that the treatment they had received through 
the system was helpful in educating them about substance use/abuse and may help them 
if and when they are ready to stop using. The one participant who volunteered to go 
through treatment said the only reason it worked was because she went for herself, 
nobody else. 
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Supporting quotes: 
• “I believe that you won’t quit until you’re ready. I will say anything to get the court 
to shut up and get out of my way, but some people never are ready and find that 
comfort, like I’m OK.” 
 
• “Nobody can get me clean. I gotta do it on my own and in my own time.” 
 
• “Somebody can’t make me get clean, it has to come from inside of me. I have to do 
that myself.” 
 
• “The only time I’ve ever been clean is when I was in jail. And, look at me now, did 
it work?” 
 
 Sub-theme #3:  Availability of Treatment or Waiting to Go to Treatment 
(Enabling). 
 The availability of treatment or waiting to go to treatment was viewed as a factor 
in decreasing or discontinuing substance use.  One participant who came in for an 
interview did so the morning she was released from the hospital because of an overdose.  
She was quite emotional and ill.  During the interview, I asked her if there was a place for 
her to go to treatment right then if she would go and she said yes.  Unfortunately, there 
was no immediate help for her, and she left the interview without a plan to enter 
treatment.  Many participants agreed that if treatment isn’t available when they are ready, 
they will not follow through.  Also, if a bed space is available in the future, and they have 
to wait, it is too difficult not to use while waiting because of the physical discomfort of 
coming off drugs without assistance, and they end up not following through with a 
treatment plan.  
Supporting quotes: 
• “I want to try and get off suboxone, but I end up drinking, and that, oh, suboxone 
feels like you’re gonna die, but then my alcohol and klonopin are the worst, and 
I’ve come off that before, and that will kill me to do it on my own.” 
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• “Once you get sick from heroin you know, and it’s all down hill from there.” 
 
• "Every person who has to wait for it [treatment] may not make it. It has to be there 
when you're ready." 
 
• “I got really high on my tolerance, and I went to get some pills, and told them 
[doctor] how much I was taking, and they wouldn’t give me any, said there was 
nothing they could do, no treatment, and I had to kick it, seven days into it not 
sleeping, seriously considering just finding an all night pharmacy, just jumping 
over the counter, taking the pills right there and not care, just to make it go away. 
There’s nothing that hurts worse than that.  Yea, you could stick electrodes on your 
genitals and it wouldn’t hurt that much.” 
  
 Sub-theme #4:  Family Dynamics (Reinforcing). 
 Family dynamics was a factor in substance use/abuse.  All participants reported 
coming from a family life that included at least alcohol abuse if not more illicit drug use.  
Even those who identified as having a “good upbringing” discussed their parents, siblings 
or other extended family members using or abusing alcohol and/or other drugs. Some 
also were introduced to drugs by their parents, and saw drug use as a way of life.  Most of 
the participants who were still using (17 of 20) viewed their childhood as the catalyst for 
continued substance use/abuse.   
Supporting quotes: 
• “If you tell a kid they’re stupid their whole life, they’re gonna think they are stupid. 
If you tell someone they’re gonna be a junkie their whole life, they’re gonna be a 
junkie, and that’s just the reality of the situation.” 
 
• “My mom got busted for selling pot and methamphetamine when I was six.” 
 
• “I actually, um I, when I was seven, I cut the big red ribbon that was around the 
capital building for the drug free task force. And for the class of 2000, they put the 
big red ribbon around the capital building, and I was the girl with the big scissors 
that got to cut it off. And then when I was in fifth grade, I uh, got, my speech got 
chosen for the DARE program to read in front of the whole entire class about how I 
wasn’t going to be a drug addict. And, because, I don’t know, because my whole 
family works in the court system I learned how to pretend really really well, that 
everything was OK, and that I wasn’t a drug addict. And, it was my whole thing 
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later that I was a “functional” drug addict and I mean, even to this day I still have 
that same theory in my head. I was taught my whole life to pretend, yea, pretend 
like everything is OK, like to be that closet junkie in the bathroom. Even most of my 
best friends didn’t even know I shot up drugs until like three years later, they didn’t 
know I shot up since I was 15 years old.” 
 
For those who had stopped using, family support was also influential in their decision to 
discontinue using.   
Supporting quotes: 
• “My brother, he didn’t compromise what I believe in. He came over to my house in 
Washington after the Hep C stuff and going back to using, he sat me down and said 
all the things that he loved about me and he said you can be so fucking stupid, 
don’t forget what I said to you, but you are being so fucking stupid right now. And 
he was crying, and it was the hardest thing for me to hear and I stepped outside of 
the box that I had jumped into. Believe me not, I smoked and used crystal meth 
until the day that I left and got in my brother’s car.” 
 
• “I couldn’t see my family hurt anymore. My niece almost died of an overdose, and I 
feel responsible for that, for turning her on to things, for not being a good role 
model. It’s not worth it, so I had to get out.” 
 
When asked what may have prevented the participant from starting to use substances, 
all had a view of it being inevitable, regardless.  
Supporting quotes: 
• “It wasn’t because of this, or because of that, it was just my turn.” 
 
• “It would have happened anyway” 
 
• “I think if I would have had more support at home, better parental roles.” 
 
• “If I could have had a different childhood.” 
 
 Sub-theme #5:  Identification with Being a Parent (Reinforcing). 
 Identification with being a parent, especially for female participants, was a factor 
for wanting to discontinue substance use.  All of the participants related that becoming a 
parent or being a good parent was a reason to be clean and get sober.   
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Supporting quotes: 
• “I need to keep my shit together for my kids, and I know I’ll quit meth sometime, I 
just need to keep it together.”  
 
• I’m 24 years old, and I’m gonna be 30 tomorrow, and, I just want to do something 
different with my life, and I want to able to have a house, and kids, and you know, a 
career, and that kind of stuff, so I moved back to Missoula.” 
 
• “I just want something better for my life and my kids.” 
 
• “We want to move to Salt Lake and hoping I can just start over and just stay away 
from that. I know I’m strong and I can do it I just have to do it. For my kids, you 
know.” 
 
• “My kids are there, but they don’t see. I go in the bathroom. In the house, yes, but 
not around them.” 
 
 Sub-theme #6:  Having a Purpose in Life (Reinforcing). 
 Having a purpose was a factor for discontinuing substance use.  One participant 
had been clean and sober at one point for a number of years, and during that time he had 
been an HIV/AIDS and Addictions Counselor. When discussing this time in his life, he 
identified the purpose he felt in helping other people as a reason to stay clean and sober.  
Although many of the participants defended their life styles and drug use, they also 
discussed that living a meaningful life would include not using drugs. 
Supporting quotes: 
• “The people in my life have said things that I can’t deny, because it is true, because 
the spirit inside of me has never been able to deny truth. That ate me alive when I 
was using, and now I feel like that can let that go and really be me.” 
 
• “I’ve done a lot, I did the education, I’ve done trainings. I like to do this type of 
work. I feel like its my duty to educate and to be a part of it, because I owe it, to try 
and help to prevent, to give back.” 
 
• “I’m studying social work. I want to make a difference, and I know I can’t do that 
this way [using].” 
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Theme #2:  Sharing Needles/Works and Unprotected Sex 
 Sub-theme #1:  Benefit of Getting High over Being Infected with HIV 
(Reinforcing). 
 The majority of participants reported that getting high takes precedence over 
staying free of HIV infection.  Only two of the 20 participants said they had not shared 
needles/works and wouldn’t, even if that was the only way to use.  Unprotected sex was 
viewed as a less risky behavior than sharing needles/works for HIV infection. Engaging 
in unprotected sex was very common among the participants, especially when they were 
under the influence of drugs. Some participants reported having sex in exchange for 
drugs, even on a casual level. Many reported using condoms when not high, but when 
substances were being used protection seemed to be a non-issue for most. 
Supporting Quotes: 
•  “I was aware of HIV, but it’s amazing what you don’t think about when you use. 
What’s important is the getting high and later, like the next day you may think 
about it. Oh, shit, you know.” 
 
• “We’re all in the same game, you know what I mean? And I don’t want to see any 
of my friends dead, you know what I’m sayin’. Even though we are killin’ 
ourselves.  Not much you can do about it. But when you’re there, getting high, 
what’s more important? Yea, you don’t care at the time.” 
 
•  “It’s just common sense just not to use a dirty rig after someone. I’ve never used a 
dirty needle after anyone yet.  It’s just common sense not to use a dirty rig. I don’t 
want anything personally. (So you haven’t shared?) No. (How about unprotected 
sex, do you think about HIV with that?) Yea, it can be transmitted that way, and 
that’s happened so far. But no, I’m not really thinking about that [HIV infection] 
during sex. We’re like rabbits or something when we’re high, and the drug is 
what’s important.  I don’t know. Like girls, they say I’m on the Depo shot, I can’t 
get pregnant, but not worried about what else they can get. I don’t ask ‘cuz it’s 
none of my business.” 
 
• “Yea, if there’s only one point [syringe], you take the risk.” 
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•  “I’m working within the boundaries, and for me I can’t stand condoms, which I 
think that’s drove my sex drive down to just about nil, unless I am high.” 
 
 Sub-theme #2:  Type of Social Networks (Enabling). 
 The type of social network that participants belong to influences the sharing of 
needles/works and the practice of unprotected sex. Two social networks were identified, 
the acquaintance network and the kinship network.  
In the acquaintance network, members are affiliated primarily through their drug 
use.  A member may be a person an IDU gets the drug from, or someone they are 
acquainted with for only the time that they shoot together.  Some of the participants 
reported sharing within this network, but it was not a common theme.  Individuals who 
did share within this type of network reported that they asked if their acquaintance was 
disease free, and trusted the answer.  Also, those who were Hepatitis C positive who 
shared within this network reported disclosing their status to individuals with whom they 
shared needles and works prior to sharing. 
 The other social network identified was the kinship network.  Within this 
network, members consider their fellow members friends, family - “blood”.  There is a 
sense of trust and loyalty among members.  All participants who shared needles/works 
within this context commented on their trust in the people with whom they shared. 
Unfortunately, this trust and loyalty was not always warranted as individuals in this 
kinship network also occasionally shared needles outside of the network.  In addition, it 
was not uncommon for them to engage in unprotected sexual behavior outside of the 
network.  These high risk behaviors were not revealed to the other members of their 
kinship network, as revealed through the interviews. 
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Supporting quotes: 
• “Yea, I definitely want to find out [HIV status] ‘cuz like me and A. [member of the 
kinship network] have been talking about getting back together and I shared a 
needle with this junkie in Seattle when I did it, and I did it a pocket full of times.  I 
really do love the girl, whether she hates me or not and I’d really hate to, uh, bring 
something back to her. Yea. “Cuz, um, we both got Hep, she got Hep from me. That 
junkie said he didn’t have AIDS, but I don’t know, you know. If I do got it, I hope I 
don’t give it to her. But most of us junkies are pretty honest with each other about 
that.” 
 
• “Well, I only share with him [a member of the kinship social network], so I don’t 
worry about that.” 
 
• “I was usually the one who bought the drugs and got the drugs and so I went to the 
bathroom and I’d do the drugs the way I wanted to do them [inject], and then came 
out and did it with my friends the other way so they never even assumed.” 
 
• “I only share with my boyfriend. We used a point with somebody we know, but we 
know them. (How about unprotected sex?) No, I’m with my boyfriend.” 
 
• “I was tested [for Hep C] and was told that I have it. My boyfriend doesn’t know I 
have it, so this information isn’t going anywhere, right? Yes, I have unprotected 
sex, but only with my boyfriend for four months and we have unprotected sex and 
we want to have a kid and I know it is OK to have a kid with Hep C because only 
6% of children get it from the parent. I know I can live 40 more years with it.”  
 
 Sub-theme #3:  Knowledge about the Efficacy of Cleaning Needles/Works, and of 
the Risk Associated with Unprotected Sex (Predisposing). 
 Knowledge about HIV and Hepatitis C was high among all participants as 
reported earlier. Many reported cleaning needles/works as a harm reduction method for 
HIV infection. However participants who were Hepatitis C+ reported not knowing that 
simply cleaning syringes doesn't always protect against Hepatitis C infection.  Also, 
being under the influence affected how safe participants were with harm reduction 
techniques and behaviors. If they were “high” they tended not to be as diligent with 
prevention efforts.  In addition, the perception of “safer sex” influenced their decision to 
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engage in unprotected sex. “Safer sex” was defined as simply knowing their sexual 
partner rather than using a condom every time they engaged in sex. 
Supporting quotes: 
• “She got Hep from me.  That’s definitely from sharing.  At first we didn’t, we 
always kept ourselves [works] separate, and then she got drunk one night and used 
our stuff and then we went to Santa Cruz and we got tested and she turned up 
positive.” 
 
• “I never knew – I was reading that thing [brochure] out there that you have on 
Hep C that you have to swish it around for two minutes, and not even 100% bleach 
is effective.” 
 
• “I found out [Hep C status] when I was pregnant. Yea, I didn’t know until now 
when I read that thing that bleach doesn’t kill it. We cleaned it [syringe], but that’s 
probably what happened.” 
 
• (Have you shared needles?) “Yea, but I didn’t know bleach didn’t kill Hep C. I 
didn’t know that until homeboy told me.  Anyway, it was my roommate [who he 
shared with], nobody I didn’t know. It’s still in the back of my mind now. That takes 
the whole bleach thing and throws it out the window. (How about sex?) I’m with 
my girlfriend, so I don’t worry. We’ve been together for two years now.” 
 
• “I don’t have too much to worry about, because I’m an outie [male], not an innie 
[female], you know. It’s easier to get AIDS through needles than sex, you know 
what I mean? I’ve done it with guys, and with girls, I like girls.” 
 
 Research Question:  What are the resource and/or prevention service needs 
for IDUs? 
Theme #1:  Access to Clean Needles 
 There was an overwhelming response for access to clean syringes.  All 
participants reported accessing Needle Exchange Programs (NEPs) when traveling or 
living outside of Montana.  Participants reported receiving not only clean needles and 
other injection materials, but also HIV education, HIV counseling and testing, harm 
reduction information for safer injection, substance use/abuse treatment information, and 
Hepatitis C education and testing. If a formal NEP was not accessible, participants 
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suggested user-friendly pharmacies where IDUs could purchase needles without 
discrimination, or physician prescriptions for clean syringes.  All participants who shared 
needles stressed the fact that if they didn’t have access to clean syringes they would opt 
to share needles/works to get high. 
 For the residents of reservations, access to clean needles was identified as an 
important need, although a visible NEP did not seem as viable in this location.  
Confidentiality was identified as a barrier to accessing such a program, and participants 
said other private means of accessing clean needles should be available. 
Supporting quotes: 
• “Needle exchange saved my life, I’m sure of it.” 
• “Wind carries gossip around here [on the reservation].  I want clean needles, but I 
don’t want my brother to know where I get them.” 
 
• “There definitely needs to be a needle exchange, because if you’re going to do it, 
you’re going to pick it up out of the gutter and do it. I’ve seen people do it. Pick it 
up out of the gutter and do it. I agree, if you want it that bad, you’re gonna do it. 
Nothing’s gonna stop you. Your friends can’t stop you, nobody gonna stop ya. So, I 
mean, I’ve seen it, watched it, I’ve done it myself, filed it down on a match book 
before, get it sharp and put it back in your arm. So, if you’re gonna do it, you might 
as well be able to get a clean one and do it right. Cuz you can’t stop ‘em.” 
 
• “I think that every town should have a needle exchange and that people should 
have information on what to do if someone is overdosing. I think just educating 
people on things and just having a needle exchange in itself, you know, you’re not 
promoting drug use, and that’s the biggest controversy about having a needle 
exchange anywhere is that if you have it then you’re saying that it’s OK to do 
drugs. But that’s not the reality. The reality of the situation is that people are going 
to do drugs whether you want them to or not. And you can give them the materials 
so that they can be safe at least with it then you’re gonna stop the spread of 
disease, you’re gonna get more aware, you’re gonna get people who are working 
in these places that if someone really did want to get help that they could get them 
to it.” 
 
• “If they had needle exchange it would be good, but it could be bad at the same time 
‘cuz there would be like dirty needles all along the river, like in the pond in San 
Francisco, I don’t want to see that, like when I want to go someplace in a nice 
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comfortable place along the river and just chill, I don’t want to see like dirty rigs in 
the river. But, then again, it would be good if people for to stay clean.” 
 
• “Sharp bins, sharp bins [needle exchange]. And clean up after yourself.” 
 
• “To get points at a pharmacy, you got to show ID, you gotta sign for it, and if I 
gotta do that, then no, no I’m not gonna do that.” 
 
• “With needle exchange, I always had brand new ones, didn’t matter, and I didn’t 
have to sharpen on a match book, and so on.” 
 
• “They are RNs there at the exchanges, they taught people how to shoot up, how to 
use tie offs, and to use release, and gave the education of well, if you can’t stop 
using, don’t want to stop using, here is what you need to do to eat, to keep your 
body functioning. Not just HIV education, but things on nourishment, harm 
reduction, better needles, and stuff.” 
 
• “There should be a place where you can get clean stuff, ‘cuz you know.  Education 
is a moot point, people already know. They just, they don’t care. Stupid, they’ll do 
it themselves, you know. I guess I’ve done it, share.” 
 
Theme #2:  Substance Abuse Treatment 
 Participants stressed that, even though readiness is a factor in accessing treatment, 
the availability of treatment is vital.  Participants felt that substance abuse treatment in 
general – in-patient, out-patient or other treatments were not available. Also, if treatment 
were available, the cost to go to treatment was prohibitive for most to participate.  
Supporting quotes: 
• “I think good or free treatment, like if you have a real problem, you can get rehab 
and other stuff you need. And don’t just put them on a script that they can get 
addicted to, like don’t give them speed if they’re addicted to meth – or xanax if 
they’re addicted to klonopin – duh. I was talking to my mom, she’s a nurse 
practitioner, and she says that’s what they do. Tradin’ Rice Crispies in for 
Cheerios – its all cereal.” 
 
• “Definitely treatment. But what treatment? There is none. And I couldn’t afford it if 
there was.” 
 
• “I don’t think people even know about the treatment center I went to. It’s for youth, 
but hardly anyone knows about it, and I don’t know how easy it is to get into it 
anyway.” 
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Theme #3:  Harm Reduction Services until Ready for Treatment 
 Participants reported the need for harm reduction services to stay HIV free.  Harm 
reduction services included contact with Outreach Workers, free HIV and Hepatitis C 
counseling and testing, and access to service organizations such as the Salvation Army, 
food banks and job skills training.  
 For participants who had been in contact with Outreach Workers, they referenced 
outreach work as a necessity for them.  Not only did they receive HIV and Hepatitis C 
education and information, they received HIV counseling and testing and harm reduction 
supplies and referrals to other agencies.  In addition, they reported that receiving these 
services from people they trusted was very important for them to feel safe and not judged. 
 Participants reported the need for free HIV and Hepatitis C testing.  Every 
participant who did not know their Hepatitis C status received a free Hepatitis C Home 
Test kit.  This kit costs $54.00, and all reported that they would not have taken the test if 
it hadn’t been free.  In addition, participants reported that free testing needs to be 
available in settings where they feel safe, not judged and where they know their 
confidentiality would not be breached.  
 Participants reported the need for service agencies that provided food, clothing 
and shelter.  Service agencies were viewed as organizations that provided some stability 
for IDUs and allowed them to make better choices.  In addition to providing basic 
services, the need to have HIV and Hepatitis C information at these agencies was also 
identified. 
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Supporting quotes: 
• “We need more people like [outreach worker].  She’s cool, and she’s been very 
helpful.  She came to us, we didn’t have to find her.  She told us about you [the 
interviewer]. Yea, she helped us out.” 
 
• “Stuff on Hepatitis C, like I saw in New York City. They had free tests, free 
medicine, and a lot of information for us about Hep C. Yea, I think that was at the 
needle exchange there too.” 
 
• “Somewhere that helps out with housing, clothing and stuff. There’s a bunch of 
different places out there but no one wants to help someone get on their feet. You 
can stay at the Povarello Center, but if you got a girlfriend, you sleep apart.  I’ve 
seen the one-stop shopping before for all those things to help you get back on your 
feet.” 
 
• “The best suggestion to influence these people is maybe like set up a day program 
like a day center like they had in California, a drop-in from 9-5, where people 
come out and talk, have support groups, stuff like that. You know, that would be 
wonderful, like,’ hey, how are you doin’ today?’ Right, like something that shows 
that they care, ‘cuz a lot of these people feel like they don’t have no one that cares. 
I’ve felt like that all my life.” 
 
Theme #4: Reaching IDUs with Prevention Messages 
 Participants reported the importance of getting HIV prevention information out 
into the community where it is easily accessible to IDUs.  Participants identified the 
following best ways to reach IDUs with HIV and Hepatitis C prevention education and 
information:  
• Sending media messages that are non-judgmental and include accurate and 
detailed prevention information;  
• Using documentaries on people’s lives who are dealing with substance abuse 
problems and live with HIV and Hepatitis C; 
• Providing education in schools, treatment centers, and in jails/prisons; and 
• Illustrating through pictures the changes in physical appearance that occur 
over time with chronic drug use.    
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Supporting quotes: 
• “Just get the real stuff [information] out there, you know. If they’re gonna do it, 
they’re gonna do it, just let them know what they’re getting themselves into, that’s 
for sure, like Hep C. If I had known, if I knew, you know this is twelve years later, 
but uh, I’d never done it.” 
 
• “If you guys were to make bill boards, make one like “Don’t Share”, instead of 
don’t do it. Like, have two arms, two right arms, two different people with a needle 
in between them and it says, “Don’t share.” That’s a great idea, you might get 
famous with that one, that’s right.” 
 
• “They [the Meth Project] just try to tell you not to do it and that’s it. I think that’s 
crap, like the bill boards. They have a point, don’t do it, but what about the people 
who have already done it and are already doing it and want help and need help, 
you know, their whole approach is don’t ever do it. People who already do it, it 
doesn’t work. It’s just kind of a joke. Like, not even once. Maybe to a five year old. 
It’s ridiculous, irrelevant.” 
 
• “Just to get out of denial that Montana doesn’t have drug addicts here and do 
something about it.” 
 
• “To be out in the community with the information, not stuck back in the corner of a 
building.” 
 
• “There’s nothing said about HIV or Hep C risk said in the Meth Project. It’s kind 
of a waste. Unfortunately the most I know who are infected got that way being 
intoxicated or out of their mind high. Why don’t they say that?” 
 
• “Montana is growing, people are coming in, and for those of us who are positive, 
people are coming in, and we’re growing. We gotta let people know that.” 
 
• “You know, like those pictures of that woman who used and got real gross, and 
show what really happened to her, not by just once but by ten years of the shit.” 
 
•  “Education is huge. Get the word out. Gosh, I don’t know, it takes a huge society 
change to have people who have been diagnosed, to be um, maybe just send me 
around the world to talk! People who are comfortable with it. People who have had 
experience with drug use or not just drug use but other abuse, be open, and talk, 
talk, talk. Tell the kids they are our future.” 
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 Research Question:  What are the barriers to accessing services? 
Theme #1:  Stigma and Discrimination 
 Stigma and discrimination were identified as the largest barriers to accessing 
services.  While HIV/AIDS carries a stigma of its own, substance use/abuse, and being an 
IDU also ranks high in stigma and discrimination.  IDU participants identified 
discrimination as a barrier to accessing services, including getting tested for HIV and 
Hepatitis C, accessing medical treatment and substance abuse treatment services.  
Participants who had accessed clean syringe programs in other states maintained that the 
stigma was heightened here in Montana.  Also, IDU participants who identified 
methamphetamines as their primary drug of choice believed that the current Meth Project 
Campaign added to the stigma and discrimination that they experienced.  
Supporting quotes: 
• “I think the Meth Project has made it worse for us who use. I get treated 
differently, like we’re all bad people. When I go in to get medical treatment, the 
health people treat me like shit. And then I don’t want to say what‘s really goin’ on, 
‘cuz they just look at me like I’m a piece of shit.” 
 
•  “The best way to get high is to inject, but people look down on it man. Like, it’s 
better to smoke it or snort it or something! That’s crazy if you think about it.” 
 
• “Put a big bill board, fucking anti-not even once commercial bill board. That 
would be cool. That would serve them meth people right. It just drives me nuts ‘cuz 
I never been a tweaker like that. Tweakers, I’ve seen some nasty shit that tweakers 
have done, but I’ve never see nasty people. I think they’re [the meth ads] stupid. 
Everybody knows that meth’s not like that. That’s not how it really is.” 
 
• “Not looking down on people. Especially for shooting up. There’s a real stigma 
attached to it. In my opinion, it’s one of the cleanest ways. Like when you smoke it 
you get all that other shit your lungs and crap.” 
 
• “The fear.  They all stare at you like they want to see you on America’s Most 
Wanted.” 
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• I don’t care what people think of me or how they look at me like, I just think people 
should be more accepting of knowing that there is help out there, free help, free 
ways to express love for yourself, by getting checked out, you know.” 
 
• “I think people think people shouldn’t even go into places like that [needle 
exchanges], that it’s wrong to even go into a place like this because it’s wrong to 
be putting yourself at risk.” 
 
• “They’re embarrassed and scared. Being seen as a drug user.” 
 
• “You don’t want to go in and have people tell you that what you’ve been doing is 
bad. No matter what anyone says when you’re coming off something it don’t help 
anything that you’re feeling inside. Feeling like shit already don’t need another 
dose of it. You don’t need to hear about how bad of a person you are because of 
what you’ve done and then you’re feeling like crap already.” 
 
• “We need people who are in it that we can trust, people like you. Your vacation to 
Colorado [interviewer going to treatment], you know, when you share that, it feels 
more trusting with you. I can come and talk to you, and that’s what people need. 
Even if there is some type of buddy system, get to know people, help people love 
themselves more, or like themselves at least.” 
 
Theme #2:  Confidentiality  
 Confidentiality was viewed as a barrier to accessing services, especially for IDU 
participants who resided on reservations.  Confidentiality was seen differently than 
stigma and discrimination.  It wasn’t a fear of being treated poorly, but rather a fear of 
close friends or family knowing that they were accessing services. 
Supporting quotes: 
• “It’s like the moccasin telegraph out here.” 
 
• “Wind carries gossip around here [on the reservation]. I want clean needles, but I 
don’t want my brother to know where I get them.” 
 
Theme #3: Fear of Being Arrested and Incarcerated for Drug Possession 
  Although not an overall consistent theme, the fear of being arrested was 
identified as a barrier to accessing services.  Some participants reported the need to 
decriminalize the possession of paraphernalia.  If this law was changed, these participants 
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felt that they would be more willing to dispose of dirty needles appropriately and to 
access services more readily. 
Supporting quotes: 
• “Instead of busting somebody with a dirty point in their pocket, get down on the 
bigger guys. Not the person who is crying out for help or don’t even know they are 
cryin’ out for help. And that’s the truth of it.” 
 
• “Yea, our friend was fallin’ out [overdosing], and we couldn’t do anything but take 
her up to the ER door and run.” 
 
 
Key Informant Interview Results 
Section 1:  Description of the Study Sample 
 Key Informant interviews were conducted during and after IDU Participant 
interviews.  Data collected was used to corroborate and augment the IDU participant 
interview data. 
 Seventeen Key Informant interviews were conducted.  Twelve interviews were 
conducted face to face, four were conducted via telephone, and one was conducted by the 
Key Informant answering the interview questions with pen and paper and returning them 
to the researcher via postal mail.  No direct quotes are included in this section of the 
results, because the Key Informant interviews were not audio recorded.  Rather, detailed 
notes were taken during the interviews.  All regions of Montana (see Appendix E) were 
represented in the study sample.  Professional affiliation of the key informants included: 
• City/County Health Departments (2) 
• Corrections/Drug Court (2) 
• HIV/AIDS Service Organizations (1) 
• IDU Outreach Services (4) 
• Mental Health Services (1) 
• Needle Exchange Services (Washington state affiliated) (2) 
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• Hepatitis C affiliated Services (1) 
• Social Service Agencies (1) 
• Substance Abuse Treatment Services (3) 
Section 2:  Identified Themes Related to Research Questions 
 Research Question:  What Factors Influence High Risk Behaviors? 
Theme #1:  Substance Use/Abuse 
 Sub-theme #1:  Availability of Treatment (Enabling). 
 The availability of treatment or waiting to get into treatment was viewed as a 
factor to decreasing or discontinuing drug use.  Specifically, when IDUs decide to 
discontinue using drugs, immediate availability of treatment services is a major 
determinant of whether or not they follow through with the behavior change.  If IDUs 
have to wait for treatment, it is more likely that they will change their mind before 
something is available to them.  Also, most key informants acknowledged that treatment, 
in general, is not available to IDUs. 
 Sub-theme #2:  Having a Purpose in Life (Reinforcing). 
 Key informants identified having a purpose in life as a factor for discontinuing 
drug use.  Low self-esteem, feelings of hopelessness and lack of motivation were 
identified as factors to continuing using drugs.   
 Research Question:  What are the resource and/or prevention service needs 
for IDUs? 
Theme #1:  Substance Abuse Treatment 
 Key informants stressed that while the availability of treatment as vital to 
recovery, in-patient, out-patient or other treatments are not readily available to IDUs.  In 
addition, longer, more effective treatment is needed for methamphetamine users, and 
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should be accessible through means other than the criminal system.  Even if treatment 
were available, the current cost to go to treatment is prohibitive for most.  In addition, 
treatment that allows mothers to keep children in their care while in recovery was 
identified as a need.  For IDUs within the correctional system (drug court), harm 
reduction treatment services are needed to provide IDUs with education and support to 
decrease or stop using drugs while waiting for a space in treatment.  Drug rehabilitation 
rather than long term jail sentences is needed for individuals incarcerated for drug 
possession crimes. 
Theme #2:  Free Hepatitis C Testing and Other Hepatitis C Information and 
Education 
 Key informants reported the need for free Hepatitis C testing and distribution of 
Hepatitis C information.  Key informants said that Hepatitis C is the disease that IDUs 
identify with more so than HIV.  IDUs can be engaged in HIV prevention through 
Hepatitis C education and services.  In addition, free testing needs to be available in 
settings where participants feel safe, not judged and that their confidentiality would not 
be breached.  
Theme #3:  Access to Clean Needles and HIV Education and Information 
 Access to clean syringes was identified as a need for IDUs.  Key informants felt 
IDUs would share needles/works if clean injection supplies are not accessible.  One key 
informant reported that past efforts to collaborate with pharmacies to provide clean 
syringes “fizzled”.  In addition to clean needles, HIV educational information, HIV 
counseling and testing and harm reduction information for safer injection was identified 
as a need for IDUs.  One Key Informant said that although they were not allowed to use 
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funds to distribute clean needles, they would support and refer clients to services that 
offer clean syringes.  
 Research Question:  What are the barriers to IDUs accessing services? 
Theme #1:  Stigma and Discrimination 
 Stigma and discrimination was the largest barrier identified for IDUs accessing 
services.  All data paralleled that of IDU Participant interview data. 
Theme #2:  Cost of Treatment  
 The cost of substance abuse treatment was identified as a barrier to IDUs 
accessing services.  Substance abuse treatment on all levels needs to be very low or no 
cost for IDUs to be able to access these services. 
Theme #3: Services Not Available 
 The mere fact that services such as access to clean syringes and substance abuse 
treatment options are not available in Montana was identified as a barrier to accessing 
services.  
 Research Question:  What are the barriers to implementing services? 
Theme #1:  Lack of Funding 
 Lack of funding was the largest barrier to implementing services.  Key informants 
recognized the importance of HIV and Hepatitis C prevention and how these topics are 
interrelated to issues such as substance abuse; however the lack of funding for substance 
abuse treatment alone creates a large barrier to implementing adequate services for IDUs.  
The lack of funding for substance abuse treatment in jails and prisons was also noted. 
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Theme #2:  Lack of Agency Networking 
 Lack of agency networking was viewed as a barrier to implementing HIV 
prevention services to IDUs.  There is a lack of coordinated efforts between HIV 
prevention, mental health and treatment services.  For example, agency collaboration 
between HIV/AIDS service organizations and substance abuse treatment programs is 
needed to provide HIV prevention education to those who are in treatment.  Also, agency 
networks that provide other social services such as food, clothing and shelter should 
collaborate with HIV/AIDS service organizations to educate and inform clients of 
services available for HIV and Hepatitis C. 
Theme #3:  Services Prohibited or Discouraged by State and Federal Laws. 
 Although access to clean syringes was identified as a need for IDUs, Key 
Informants also identified barriers to implementing these services.  Montana state law is 
written to criminalize those who possess syringes.  Also, access to clean syringe services 
cannot be funded by federal dollars. 
Documentation and Archival Records Results 
Section 1:  Description of the Study Sample 
 Documentation review and archival record retrieval was conducted during and 
after the collection of IDU Participant interview and Key Informant interview data.  The 
documentation and archival record information collected was used to corroborate and 
augment IDU participant and Key Informant interview data.  The following data sources 
were researched: 
• Internet searches specific to HIV/AIDS websites for Montana; 
• Montana State Departments (Health and Human Services, Addiction and 
Mental Health Services, Department of Corrections, Department of Justice); 
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• State statistical data for correctional and substance abuse facilities; 
• Major Montana newspaper media sources; 
• Montana task force and council documents specific to HIV and drug use; 
• National data sources that included Montana specific data; 
• Major Montana television sources; and 
• Published media articles specific to HIV, IDU and Montana. 
 
 More than 10,000 Montana newspaper articles related to injection drug use were 
accessed through a search done for the period of January 1, 2002 through September 26, 
2006 (see Table 4 below).  In addition, more than fifty internet websites were accessed 
and hundreds of documents were reviewed for data collection.  The documents cited 
below are those that were relevant to answering the research questions and that supported 
IDU Participant and Key Informant interview data. 
Section 2:  Data Contributing to Answering Research Questions and Supporting 
Interview Data. 
 Research Question:  What Factors Influence High Risk Behaviors? 
Theme #1:  Substance Use/Abuse 
 Sub-theme #1:  Type of Drug Used (Enabling). 
 Methamphetamine use in Montana is prevalent.  Nationally, the rate of substance 
abuse treatment admissions for primary methamphetamine abuse increased between 1993 
to 2004 from 13 per 100,000 to 85 per 100,000 population aged 12 or older.  In 2004, 18 
states had rates in excess of the national rate; Montana ranked 9th highest with a rate of 
133 per 100,000. The route of administration differed by rural/urban status: the 
percentage of methamphetamine admissions that smoked the drug was highest in the 
most urbanized counties (62%) and lowest in the most rural counties (48%).  In contrast, 
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the percentage of methamphetamine admissions that injected the drug was lowest in large 
metro areas (14 to 15%) and highest in small and non-metro areas (24 to 25%) 
(SAMHSA, 2006).  
 According to the Montana Department of Corrections (DOC), 80 to 85% of all 
offenders in the criminal justice system have a drug or chemical dependency problem; 
about 53% of female inmates identify methamphetamine as one of their drugs of choice, 
and about 36% of male inmates identify methamphetamine as one of their drugs of choice 
(Board of Crime Control, 2006).   
 Admissions to Montana state-approved chemical dependency treatment programs 
in which patients listed methamphetamine as their primary drug have increased 70% over 
the past six years. This data is reflected in Table 3 below. 
Table 3.  Methamphetamine Admissions to State-approved Treatment  
     Programs, 2001-2006. 
Year Number of Admissions 
2000 734 
2001 820 
2002 903 
2003 1012 
2004 1124 
2005* 1246 
* Of the 1,246 patients in 2005: 
• 42.8% named injection as the primary route of use 
• 711 (57%) were men, 535 (42%) were women 
• About 65% were ages 18-34 
 
    Source: Montana Department of Justice, 2006. 
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 Research Question:  What are the resource and/or prevention service needs 
for IDUs? 
Theme #1:  Substance Abuse Treatment 
 The Montana State Department of Public Health and Human Services Addictive 
and Mental Disorders Division endorses 69 chemical dependency treatment programs 
throughout the state (see Appendix F).  These programs offer detoxification, out-patient, 
in-patient, Assessment Course & Treatment (ACT) classes, Minor in Possession (MIP) 
classes, or a combination of these services.  Of these programs, only five offer in-patient 
residential treatment.  Montana Chemical Dependency Center (MCDC), located in Butte, 
MT, is the only state funded in-patient treatment facility available in Montana. For this 
reason, MCDC is the focus of the documentation review. 
Montana Chemical Dependency Center 
 The Montana Chemical Dependency Center (MCDC) currently has 76 beds, with 
70 treatment beds and six detoxification/medical beds.  Treatment services are provided 
24 hours per day, seven days a week, 365 days per year.  Patient admission can be 
voluntary, court ordered or court committed.  Patients are responsible for payment of 
services based on their individual ability to pay, which is assessed at the time of 
admission and is determined by annual income.  Applicable third party payments for 
services may also be utilized.  Individuals determined to have no ability to pay may 
receive service at no charge. 
MCDC 2005 Annual Report 
 MCDC had a 3.2 million budget for fiscal year 2005, a steady increase from $2.6 
million in 2001.  The cost of treatment has increased from $139.43/day in 2001 to 
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$170.14/day in 2005.  The average length of stay for a MCDC patient is 34.5 days, which 
makes the average total cost of treatment in 2005 approximately $6,000.00.  Total 
admissions for MCDC decreased from 816 in 2001 to 542 in 2005.  In the MCDC 2005 
Annual Report sites the following reasons for this decline: 
 “We continue to suffer from critical clinical staff vacancies and extended illness 
of some of the remaining staff.  The staffing pattern of MCDC is very low, making us very 
fragile when we experience staff absence for any reason and this is exponentially 
compounded when it occurs for any length of time, as we have no depth in staffing to call 
on for these situations.  The most notable impact is evidenced in our average daily 
population and total admissions that continue to be below bed capacity, but are 
consistent with patient to staff ratio requirements of 8:1.  We have made some 
adjustments to our admission practices which allow us to address patient needs more 
effectively and insure admissions with a very modest waiting period, while 
accommodating emergency admissions” (page 5).  
 To summarize, MCDC’s annual admissions has decreased from 816 to 542 
patients (a difference of 274) not because of available space but because of inadequate 
staffing.  In addition, the cost of care has increased from $139.43/day to $170.14/day 
since 2001, an increase of $30.71/day, or an average total cost of approximately $1,075 
for an average 35 day stay.  Furthermore, the average length of wait to get into MCDC is 
approximately three to six months (MCDC, 2006). 
Montana Department of Corrections and Other Substance Abuse Treatment Data 
 The Department of Corrections Advisory Council reported, “The Probation 
Intervention Project has been initiated to create designated inpatient chemical 
dependency treatment beds at Montana Chemical Dependency Center for probation 
violators at risk of revocation.  Eight beds will be available throughout the year for DOC 
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placements referred from Probation Hearing Officers and recommended by Licensed 
Addiction Counselors.” 
 A 2001 Needs Assessment on Integrated Substance Abuse Treatment for Montana 
concluded that “Montana would be justified in considering expanding its treatment 
services.”  The analysis produced evidence of a substantial number of people who had an 
active addictive disease in the past year but on a small percentage of them received 
treatment in the past year and in their lives” (McAuliffe, Dunn and Sahady, 2001, page 
XII-15).  The Office of Applied Studies, Substance Abuse & Mental Health Services 
Administration (SAMHSA) reported that in 2003-2004, Montana ranked in the top 5th 
percentile for Needing But Not Receiving Treatment for Alcohol Use or Illicit Drug Use 
in Past Year among Persons Aged 12 or older. 
Theme #2:  Hepatitis C Testing 
 Statewide, through City-County Health Departments, an individual can receive a 
Hepatitis C antibody test for $45.00.  It takes one week to receive test results.  In 
Missoula County, more than 60 Hepatitis C tests have been positive so far this year, and 
more than 100 were positive in 2005 (Goldberg, unpublished data, 2006).  The reported 
risk behavior was sharing needles.  
 The Department of Veterans Affairs has started offering Hepatitis C testing in the 
past year.  
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 Research Questions:  a) What are the barriers to IDUs accessing services? 
and b) What are the barriers to implementing services? 
 Themes: #1) Fear of Being Arrested and Incarcerated for Drug Possession; 
 and #2) Services Prohibited or Discouraged by State and Federal Laws 
 The Academy for Educational Development, with funding from CDC, produced 
documentation on the impact of criminal laws of the safe disposal of used syringes by 
IDUs in Montana.  The document addresses four domains of law that could influence 
syringe behavior of IDUs: 
• Drug paraphernalia laws; 
• Syringe prescription laws; 
• Laws and regulations governing syringe exchange programs; and  
• Drug possession laws. 
Under the drug paraphernalia law, The Drug Paraphernalia Act states: 
 “It is unlawful for a person to use or to possess with intent to use drug 
paraphernalia to… inject, ingest, inhale, or otherwise introduce into the human body a 
dangerous drug. A person who violates this section is guilty of a misdemeanor and upon 
conviction shall be imprisoned in the county jail for not more than six months, fined an 
amount of not more than $500, or both.” (Mont. Code Ann. § 45-10-103) 
Under the Syringe Prescription Law, a prescription is not required for the purchase or 
possession of a syringe. 
Under the Syringe Exchange Legislation, Montana has no legislation specifically 
authorizing syringe exchange.   
Under the Drug Possession Law, Montana law states: 
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 “A person commits the offense of criminal possession of dangerous drugs if the 
person possesses any dangerous drug, as defined in 50-32-101.” 
 The drug paraphernalia law makes it a crime to use a syringe for drug injection.  
Under this law, the used syringe would be evidence of a past crime.  By exposing an IDU 
to arrest, the paraphernalia law in Montana could have an impact on IDU behaviors to 
retain a used syringe for proper disposal.  The drug possession law does not specify the 
minimum amount of drug required to constitute possession.  The possession of residue of 
drug in the barrel of a used syringe may be viewed as a crime.  In that case, fear of arrest 
for drug possession could deter IDUs from retaining syringes for proper disposal. 
 The Academy for Educational Development’s recommendations include: 
• Amending the drug paraphernalia law to exclude syringes; 
• Amending the controlled drug act to require a minimum specified quantity to 
ground a possession conviction; 
• Amending the controlled drug act to exclude trace amounts found in syringes; 
• Developing standard operating procedures within law enforcement that avoid 
stops, arrests or prosecutions based on drug residues in syringes; and 
• Educating IDUs and law enforcement to appreciate the importance of 
appropriate syringe disposal and the legality of possessing syringes in the 
course of disposal activities. 
 In contrast to Montana state laws, Washington state laws are similar to that of 
Montana, however under Syringe Exchange Legislation, Washington law specifies: 
 “Under Title 70, Chapter 70.24 (entitled “Control and Treatment of Sexually 
Transmitted Diseases”), there is a broad state statute setting out the state’s HIV 
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prevention plan; Wash. Rev. Code Ann §70.24.400.  The plan contemplates a variety of 
potential interventions and private as well as public providers, engaging, inter alia, in 
“[i]ntervention strategies to reduce the incidence of HIV infection among high-risk 
groups, possibly including needle sterilization and methadone maintenance.”  
Other Important Data 
 Theme #1:  Lack of Information and Documentation of IDU HIV Risk 
 The following table illustrates the lack of attention that the risk of HIV infection 
from injection drug use receives through media, specifically from Montana newspaper 
sources.  Of the fifteen results from the search words of both “HIV and/or AIDS and 
“injection drug use” or combination of those words, only four of them were specific to 
risk here in Montana, even though more than 20% of Montana’s HIV + population was 
infected through injection drug use.  Interestingly, a June 06, 2006 publication in the 
Billings Gazette reported that in Wyoming, more new cases of HIV in 2005 were 
attributed to injection drug use than men having sex with men.  Also, just as of November 
16, 2006, Michael Gulledge, publisher of the Billings Gazette, was appointed the 
chairman of the Montana Meth Project.  This may explain the large number of published 
articles on drug use in this media newsprint, and will more than likely continue to 
increase.  
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Table 4. Montana Newspaper Article Archives, 1/1/2002 – 9/26/2006. 
 
 
Media Source 
 
 
Search Word(s) Used 
 
 
Number of 
Results 
Number of Results with 
both “HIV/AIDS” AND 
“injection drug use” 
 
 
Billings Gazette 
AIDS 
Drug Use 
Substance Abuse 
Injection Drug Use 
HIV 
HIV Prevention 
1169 
7092 
802 
376 
661 
291 
 
 
2 
 
 
Bozeman Daily 
Chronicle 
AIDS 
Drug Use 
Substance Abuse 
Injection Drug Use 
HIV 
HIV Prevention 
857 
757 
97 
10 
37 
7 
 
 
0 
 
Great Falls 
Tribune 
 
Great Falls 
Tribune 
AIDS 
Drug Use 
Substance Abuse 
Injection Drug Use 
HIV 
HIV Prevention 
110 
200 
125 
8 
57 
20 
 
0 
 
 
0 
 
 
 
Helena 
Independent 
AIDS 
Drug Use 
Substance Abuse 
Injection Drug Use 
HIV 
HIV Prevention 
4430 
2530 
287 
108 
190 
82 
 
 
7 
 
 
Missoula 
Indepenedent 
AIDS 
Drug Use 
Substance Abuse 
Injection Drug Use 
HIV 
70  
16  
12 
-- 
150 
HIV Prevention -- 
0 
 
 
The Missoulian 
AIDS 
Drug Use 
Substance Abuse 
Injection Drug Use 
HIV 
HIV Prevention 
2745 
2408 
269 
95 
160 
69 
 
6 
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Summary of Results from All Data Sources 
The following table summarizes all data results in this chapter. 
Table 5.  Summary of Themes as Related to Research Questions. 
Research Question Theme Sub-theme 
Factors that 
Influence High 
Risk Behaviors 
Substance 
Use/Abuse 
Type of Drug Used and Social 
Perception 
• Identification of being an IDU was 
viewed as a justification of 
using/sharing needles, and just “their 
way of life.” 
• Identification with type of drug used 
formed the IDU’s perception of their 
social status. 
Readiness to Change Behavior 
• Treatment was important, but not 
effective until the person is ready to 
quite using drugs. 
 
Availability of Treatment 
• If treatment isn’t available when a 
person is ready to go, they will not 
follow through. 
 
 
Family Dynamics 
• Being a member of an alcoholic 
and/or drug using family was 
common and viewed as a factor in 
substance use/abuse. 
 
Identification with Being a Parent 
• Becoming a parent or being a good 
parent was a reason to be or get clean 
and sober. 
 
Having a Purpose in Life 
• Not using drugs was part of having a 
meaningful, productive life. 
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 Sharing 
Needles/Works 
and Engaging in 
Unprotected Sex 
Benefit of Getting High over Being 
Infected with HIV 
• Getting high takes precedence over 
staying HIV infection free. 
 
Context of Social Networks 
• Kinship and acquaintance social 
networks were identified, and sharing 
needles/works and also engaging in 
unprotected sex was common among 
the kinship network. 
• Members of the kinship network 
reported sharing needles/works 
outside of their network and within 
the acquaintance network. 
 
Perception of Safety of Cleaning 
Needles/works, and HIV Risk Associated 
with Unprotected Sex 
• Knowledge level was low regarding 
cleaning needles/works was not 
effective against killing Hepatitis C. 
• Being under the influence of 
substances affected harm reduction 
techniques and decisions to engage in 
protected sex. 
HIV Prevention 
Service Needs 
• Access to Clean Needles 
• Substance Abuse Treatment 
• Harm Reduction Services until Ready for Treatment 
• Free HIV and Hepatitis C testing 
• Services for clothing, food and shelter 
• Social Outlets and Alternatives to Substance Use 
• Prevention Messages 
Barriers to 
Accessing Services 
• Stigma and Discrimination 
• Confidentiality 
• Fear of Being Arrested and Incarcerated for Drug 
Possession 
• Cost of Substance Abuse Treatment 
• Availability of Treatment and Services 
Barriers to 
Implementing 
Services 
• Lack of Funding for Treatment and Services 
• Lack of Agency Networking 
• Policies and Laws 
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 CHAPTER V 
DISCUSSION 
 This chapter provides a synthesis of all data, and is organized in relation to 
answering the research questions.  It begins with a brief discussion of demographic and 
behavioral data, and continues with an examination of factors that influence HIV risk 
behaviors.  Treatment and service needs related to those factors are discussed along with 
barriers to implementing and accessing services.  Strategies and recommendations for 
closing gaps between needs and services are offered and conclusions are addressed.   
 It is important to note that most of the themes identified in this study related to 
more than one research question.  In other words, a theme might be described as a factor 
that influences risk behavior, it might also be described as an HIV prevention need, and it 
also might represent a barrier to accessing or implementing services.  Therefore, 
variations of several themes are discussed in more than one section of this chapter.  For 
quick reference, a summary of all themes is located at the end of chapter four. 
Demographic Variables of IDU Participants 
 IDU participants in this study represented a wide range of demographic variables.  
While people of both genders, a variety of sexual orientations, ethnicities, educational 
levels, incomes and employment statuses participated in the interviews, none of these 
variables appeared to be a distinct indicator of increased risk of infection with HIV.  
There were, however, several other factors that were indicative, not only of a higher risk 
of infection for IDUs, but also represented a greater risk of transmission of the virus to a 
person who does not use injection drugs. These factors are discussed below. 
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Factors that Contribute to High Risk Behaviors 
 
 In phase four of the PRECEDE Model, the educational and organizational 
diagnosis identifies and classifies factors that may influence a behavior.  Predisposing 
factors include a person’s knowledge, attitudes, values, beliefs and perceptions.  Enabling 
factors are comprised of resources, skills and societal forces or systems that facilitate or 
create barriers to behavior change.  Reinforcing factors comprise types of rewards that 
one may receive that either encourage or discourage certain behaviors (McKenzie & 
Smeltzer, 2005).  The following is a discussion of factors that were identified in this 
study, and how they influence high risk behaviors for HIV infection.   
Family Dynamics, Identification with Being a Parent and Having a Purpose in Life 
 Family dynamics, identification with being a parent, and having a purpose in life 
were all reinforcing factors that either encouraged or discouraged drug use.  The family 
dynamic that all the IDU participants in this study had in common was that of growing up 
in an alcoholic family.  Often drugs and alcohol were introduced by a parent or sibling 
and became a way of life.  Using was seen as inevitable.  IDU participants’ negative view 
of their childhood acted as a catalyst for continued substance abuse.  On the other hand, 
while family dynamics were often seen as reinforcing drug use, for those few who had 
stopped using, family support by a recovering family member was influential and 
reinforced their decision to discontinue using.   
 The second reinforcing factor was identification with being a good parent.  
Several IDU participants stated that the desire to become a parent, or to be a better parent, 
was a reason to be clean and sober.  The desire to be a good parent related to the third 
reinforcing factor of having a purpose in life.  Although many IDUs defended their 
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lifestyle of drugs and alcohol, their definition of living a meaningful life included not 
using drugs.  The influence of family, the significance of children, and the need to have a 
purpose in life are important factors to consider when developing HIV prevention 
education materials and disseminating information. 
Social Networks: Their Context and the Type of Drug Used within the Network  
A major theme relating to social networks was identified.  Three enabling factors 
that influenced HIV risk behavior was the type of social network to which the IDU 
belonged, the context of that social network, and the type of drug used within the 
network.  Two social networks were identified, the acquaintance network and the kinship 
network.  In the acquaintance network, members are affiliated primarily through their 
drug use.  A member may be a person IDUs get their drug from, or someone they are 
acquainted with for only the time that they shoot together.  The other social network 
identified is the kinship network.  Within this network, members consider their fellow 
members friends, family - “blood”.  There is a sense of trust and loyalty among members.   
There are several issues to consider in relationship to HIV infection within social 
networks.  First, some participants were members of both an acquaintance network and 
kinship network, and reported sharing within both networks.  Members of the kinship 
network were not aware that some members were sharing outside of their network.  Also, 
members of the same kinship network were not disclosing all personal information.  In 
one instance, a participant was Hepatitis C +, but had not disclosed this information to 
another member who happened to be not only a needle sharing partner but also a sexual 
partner.  Furthermore, members of the same kinship network were engaging in 
unprotected sex together.  In one case, two women who had the same male sex partner 
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were not aware that their male sex partner was engaging in sex with the other woman 
within the network. These attitudes, beliefs and behaviors increase all members’ risk for 
HIV infection. The diagram below maps possible routes of HIV infection in this social 
network. 
Possible Routes of HIV Infection within Social Networks. 
 
 
  
 
 
 
  
 
 
 
 
 
The influence of social networks on behaviors that put IDUs at risk for HIV 
infection is supported in the literature. Rhodes et. al identified social networks as a 
critical factor in HIV risk (2005).  Drug injecting consequences are shaped by shared 
social and group norms, as well as by the structure of social and IDU networks.  In 
addition, social and IDU networks play a role in shaping risk perceptions and behaviors 
among IDUs (Latkin et. al, 2003).  
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 Not only does the type of social network influence risk behavior, but the context 
in which the social network exists also influences that behavior.  Individuals who engage 
in needle sharing and unprotected sex often are lulled into a sense of security in rural 
states like Montana that exhibit a low a prevalence of HIV.  Results from this study and 
from the literature reveal the falseness of that sense of security.  Population movement 
and mixing contributes to the spread of HIV infection (Rhodes et. al, 2005), and 
unfortunately, most of the IDUs interviewed reported living or traveling outside of 
Montana and sharing needles.  All of them reported engaging in unprotected sex when 
living/traveling outside the state.  The geographical locations where participants lived or 
traveled were places where HIV is prevalent, and thus, these individuals undoubtedly 
increased their risk of being infected outside of Montana and then bringing the infection 
home.  
 The social network also influences the type of drug that IDUs use, which in turn 
influences the risk of HIV infection.  Specifically, IDUs whose drug of choice was 
amphetamines were at higher risk.  There are several reasons for this increased risk:  a) 
amphetamine users typically inject more times than an IDU who chooses opiates, due to 
the fact that amphetamine needs to be administered more often for a steady high; b) 
methamphetamine can increase libido and lower inhibitions, thus those under the 
influence of methamphetamine may engage in behaviors that increases HIV infection risk 
such as unprotected sex; c) methamphetamine users who are MSM reported engaging in a 
behavior called “booty bumping”, where methamphetamine is inserted into the rectum; 
this is a high risk behavior due to the possibility of the substance causing irritation to 
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sensitive tissues and causing more bleeding, hence putting the individual at higher risk 
for HIV infection. (CDC, 2006). 
 It is evident that methamphetamine is prevalent in Montana, and is a major issue 
in HIV infection risk.  In 2004, Montana ranked ninth highest in the U.S. for substance 
abuse treatment admissions for primary methamphetamine abuse (SAMHSA, 2006).  
Over the past six years, methamphetamine treatment admissions to Montana state-
approved programs increased 70 percent, and nearly half of those admitted named 
injection as the primary route of use; higher than the national average of 25 percent for 
rural areas (DPHHS, 2006).  Also, in the criminal justice system in Montana, 
approximately half of female inmates and one-third of male inmates identify 
methamphetamine as one of their drugs of choice (DOC, 2006).  Furthermore, more than 
half of the IDU participants in this study reported amphetamines as their drug of choice, 
and that they were engaging in high risk behaviors with other social network members.  
These data depict a major concern for HIV infection risk in relation to social networks 
and methamphetamine use in Montana. 
HIV Prevention Needs  
 Many HIV prevention needs for IDUs were identified in this study.  The needs are 
discussed below in relation to identified factors that influence high risk behavior.   
 These needs include: 1) substance abuse treatment; 2) harm reduction services including 
needle exchange; and 3) prevention information and education about risk reduction.  
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Substance Abuse Treatment 
 Substance abuse treatment in general was identified as a need for IDUs.  The 
unavailability substance abuse treatment was particularly salient and is an enabling factor 
that influences high risk behaviors.  When IDUs decide to discontinue drug use, 
immediate availability of treatment services is a major determinant of whether or not they 
follow through with the behavior change.  Unfortunately, as all data sources reveal, 
substance abuse treatment is not easily available or accessible to individuals seeking 
assistance.  As discovered in the documentation review, there are 69 organizations 
sanctioned by the state to treat people with substance abuse issues, but only one treatment 
center in Montana that is funded by the state and thus affordable for the majority of 
IDUs.  This treatment center is understaffed and thus underutilized.  It is worth noting 
that The Office of Applied Studies, Substance Abuse & Mental Health Services 
Administration (SAMHSA) reported that in 2003-2004, Montana ranked in the top 5th 
percentile for Needing But Not Receiving Treatment for Alcohol Use and Illicit Drug Use 
in Past Year among Persons Aged 12 or Older.  Funding of substance abuse treatment is 
a major issue in accessing and implementing treatment.   
Availability of Harm Reduction Services 
 For the most part, treatment services are only effective when individuals are ready 
to make a change. For individuals who are not ready to give up their drug use, the 
availability of harm reduction services is an enabling factor that influences high risk 
behaviors.  Harm reduction services umbrella many needs identified in this study, and 
include access to clean needles, educational outreach services, free HIV and Hepatitis C 
testing, and access to other basic services.  In addition, for IDUs within the correctional 
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system (drug court), harm reduction treatment services are needed to provide IDUs with 
education and support to decrease or stop using drugs while waiting for a space in 
treatment.  Harm reduction services are addressed in detail below.   
 Access to Clean Needles:  By far, the most important harm reduction service 
identified by IDU participants is needle exchange.  The need to get high, a reinforcing 
factor that obviously influences high risk behavior, often super-cedes the need to be HIV 
and Hepatitis C free.  If a clean syringe is not available when the urge to get high is there, 
the IDU will opt to share dirty equipment.  The availability of clean needles is paramount 
in preventing HIV and Hepatitis C infection.  As identified by IDU participants, Needle 
Exchange Programs not only provided them with access to clean syringes and works but 
also HIV educational information, HIV counseling and testing, harm reduction 
information for safer injection, substance abuse treatment information, and Hepatitis C 
education and testing.  The fact that all participants who shared needles stressed that if 
they didn’t have access to clean syringes, they would opt to share needles/works to get 
high is a direct indication that access to clean needles should be high priority for IDUs.  
Unfortunately, many barriers were identified for accessing and implementing this 
intervention.   
  Educational Outreach Services:  Knowledge about harm reduction, such as 
cleaning needles/works and engaging in protected sex, was identified as a predisposing 
factor that influences high risk behavior.  Educational outreach is the best known strategy 
for disseminating harm reduction services.  Through outreach workers, IDUs can gain 
access to HIV and Hepatitis C prevention information education about cleaning 
needles/works and practicing safer sex, free HIV and Hepatitis testing and substance 
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abuse treatment options.  In fact, the educational role of outreach workers appears to be 
one of the only ways that IDUs receive information about harm reduction.  Contact with 
outreach workers influence IDUs to reduce their high risk behaviors, and is important for 
HIV and Hepatitis C prevention (CDC, 2006).   
 Free HIV and Hepatitis C Testing:  Knowing one’s status can influence risk 
behaviors and is part of harm reduction.  Through the act of getting tested, IDUs not only 
learn their status, they also have the opportunity to become more educated and aware of 
how their behaviors directly affect their risk for HIV and Hepatitis C infection.  Free HIV 
testing is currently available in Montana, however as identified in this study, free 
Hepatitis C testing is not available and yet is prioritized as a high need by IDUs.  There 
are approximately four million cases of Hepatitis C in the U.S., compared to more than 
one million cases of HIV.  In Missoula County, more than 60 Hepatitis C tests have been 
positive so far this year, and more than 100 were positive in 2005 (Goldberg, unpublished 
data, 2006).  The reported risk behavior in nearly all cases was sharing needles. Because 
Hepatitis C is more prevalent, it is the disease that IDUs identify with more so than HIV.  
IDUs can be engaged in HIV prevention through Hepatitis C education and services.     
 Service Organizations such as Salvation Army, Food Bank, Housing and Job 
Skills Training:  In addition to education and free HIV and Hepatitis C testing, harm 
reduction also includes access to social services such as food assistance, job skill training 
and housing assistance.  IDUs identified access to such services as an important need.  
When basic life needs are being met, IDUs may be better able to deal with HIV infection 
issues (Wiebel et al., 1996).  In addition, participants emphasized the advantages of “one-
stop shopping” venues where needs for clothing, food and shelter could be accessed 
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simultaneously.  Some participants who had traveled outside Montana described drug-
free, safe and nondiscriminatory venues where they could go to socialize, receive 
information about HIV and Hepatitis C, access social services and feel that they were part 
of something.  No such venue was identified by IDUs in Montana. 
Reaching IDUs with Prevention Messages 
 Disseminating HIV prevention information was identified as an important need 
for IDUs.  Clearly, there is a lack of attention given to the risk of HIV infection from 
injection drug use in the media; particularly from Montana newspaper sources.  Study 
results revealed only minimal documentation of the relationship of injection drug use and 
HIV infection from local media sources, even though more than 20% of Montana’s    
HIV + population have been infected through injection drug use (DPHHS 2006).  On the 
other hand, the media has given a great deal of attention to the primary prevention of 
drug abuse.  The appointment of Michael Gulledge, publisher of the Billings Gazette, as 
chairman of the Montana Meth Project in November of 2006 may explain the large 
number of published articles about drug use in the Billings media newsprint. While this 
media attention is positive for the primary prevention of substance abuse it does not 
address those who currently use drugs and the risks associated with injection drug use 
and HIV infection.    
Barriers to Accessing and Implementing Treatment and Prevention Services 
 Many HIV prevention needs were identified in this study along with factors that 
influence behaviors that put IDUs at risk for HIV and Hepatitis C infection.  While IDU 
interviewees primarily identified treatment and service needs, key informant interviewees 
offered insight into barriers to accessing and implementing services designed to meet 
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these needs.  Funding for services, policy and law issues, stigma and discrimination, and 
agency networking were identified as barriers, and are discussed at length below.  
Funding 
 The lack of funding is a major barrier in many human service areas.  It is not 
surprising that lack of funding was identified as the largest barrier to accessing and 
implementing services for IDUs.  While “readiness for change” is a major factor in the 
success of substance abuse treatment, the unfortunate fact is that when IDUs residing in 
Montana believe they are ready to give up their substance use, it is difficult not only to 
access services, but also to pay for the services that are available.  Add to that the lack of 
funding for substance abuse treatment in jails and prisons, the limited funding for HIV 
prevention and treatment, and the near zero funding for Hepatitis C services in Montana, 
and the issue almost seems insurmountable.  This issue was the umbrella to many other 
themes throughout the study.  An “if only we had funding” tone was central to all key 
informant interviews.   
Services Prohibited or Discouraged by State and Federal Laws  
 Although access to clean syringes was identified as a need for IDUs, Key 
Informants identified barriers to implementing these services, and the documentation 
review supported these findings.   
 Literature supports the fact that access to clean syringes and works is an effective 
intervention for HIV prevention. Jarlais (2000) reported that increasing the availability of 
sterile injection equipment through pharmacy sales or syringe exchange is one of the 
most common and best-studied structural interventions for HIV prevention.  CDC 
supports access to clean syringes as a proven method to reduce or prevent HIV infection.  
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At least six government studies of HIV infection among IDU in the U.S. concluded that 
needle exchange programs significantly reduce new HIV infection without increasing 
drug use or the initiation of injection drugs (UNAIDS, 2006).  Despite the results, 
political opposition still prohibits needle exchange. Organizations that provide access to 
clean syringes cannot be funded by federal dollars. 
 Unfortunately, needle exchange is not available in Montana.  Policies and social 
norms are barriers to these services being available.  Our state law is written to 
criminalize those who possess syringes.  Fear of being arrested was identified by 
participants in the study as a barrier to accessing harm reduction services. This is an issue 
that cannot be overlooked when discussing needle exchange.  If this law was changed, 
IDUs may be willing to access services more readily. 
 As detailed in chapter four, The Academy for Educational Development (2000) 
document addresses four domains of law that could influence syringe behavior of IDUs. 
In summary, in Montana, it is unlawful for a person to use or to possess drug 
paraphernalia, and a person who violates this law can be incarcerated and fined.  The 
drug paraphernalia law makes it a crime to use a syringe for drug injection.  In addition, 
the drug possession law does not specify the minimum amount of drug required to 
constitute possession.  In some cases the possession of residue of drug in the barrel of a 
used syringe may be viewed as a crime.  Exposing an IDU to arrest because of the 
paraphernalia law and the drug possession law could have an impact on IDUs willingness 
to access and properly dispose of syringes  
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Stigma and Discrimination 
 Because stigma and discrimination have been major issues in addressing 
HIV/AIDS from the onset of the pandemic, it is not surprising that stigma and 
discrimination were identified as the greatest barriers to accessing services.  While 
HIV/AIDS carries a stigma of its own, substance use/abuse, and being an IDU also ranks 
high in carrying stigma and discrimination.  IDU participants identified discrimination as 
a barrier to accessing services, including getting tested for HIV and Hepatitis C, and to 
accessing medical treatment and substance abuse treatment services.  Participants who 
had accessed clean syringe programs in other states maintained that the stigma was 
heightened here in Montana.  Also, IDU participants who identified methamphetamine as 
their primary drug of choice believed that the current Meth Project Campaign added to 
the stigma and discrimination that they experienced.  
Agency Networking 
 Agency networking is vital in order to maximize limited resources and capitalize 
on HIV prevention efforts.  Lack of agency networking was viewed as a barrier to 
implementing HIV prevention services for IDUs.  There is a lack of coordinated efforts 
between HIV prevention, mental health, corrections and substance abuse treatment 
services.  For example, agency collaboration between HIV/AIDS service organizations 
and substance abuse treatment programs is needed to provide HIV prevention education 
to those who are in treatment.  Also, agency networks that provide other social services 
such as food, clothing and shelter should collaborate with HIV/AIDS service 
organizations to educate and inform clients of services available for HIV and Hepatitis C 
prevention and treatment.  At first glance, this theme may seem insignificant compared to 
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other themes identified in this study.  However, to overlook the obvious could detract 
from possible positive outcomes in HIV prevention in Montana.  For example, research 
shows that coalition building and community consultation are critical steps for the 
acceptance and sustainability of syringe exchange programs.  Communities that 
successfully implemented syringe exchange programs were those with activists willing to 
push the agenda, public officials willing to exercise leadership, researchers able to 
present authoritative findings, and proponents who effectively mobilized resources and 
worked to build community coalitions, using persistent but non-adversarial advocacy 
(Downing et. al, 2005).  
Recommendations for Closing Gaps between Needs and Services 
 Closing gaps between the HIV prevention needs of IDUs and current services 
available can improve HIV prevention efforts in Montana.  Recommendations are as 
follows:  
Ensure collaboration between service agencies and HIV prevention services. 
 Agency networking and collaboration is vital to HIV prevention education as well 
as to providing needed services for IDUs.  Researchers recommend developing an HIV 
Prevention Coalition where service agencies provide a continuum of assistance and 
services to IDUs.  Not only could this coalition address specific HIV prevention needs of 
IDUs in Montana but also provide networking among agencies to increase substance 
abuse treatment services, expand Hepatitis C education and services, address policy 
issues and work to eliminate stigma and discrimination of IDUs and HIV/AIDS.  An 
example of such a coalition is Missoula’s At Risk Housing Coalition (ARHC).  This 
coalition model has been successful in providing housing assistance on a continuum and 
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includes not only housing services but also ancillary services that meet other needs of 
those at risk for homelessness.  Information on this coalition model can be found at 
http://www.co.missoula.mt.us/measures/arhc.htm. 
Research strategic options and formulate a plan for gaining access to clean syringes. 
 HIV prevention specialists in Montana have recognized the need for access to 
clean syringes for many years (MTAP, unpublished data, 2003; Keup, 1999).  CDC has 
myriad information regarding the effectiveness of clean needle access on preventing HIV 
infection (CDC, 2006).  A strategic plan to implement a working program for access to 
clean syringes in Montana is greatly needed at this time. To decrease the barriers to 
accessing services for clean syringes, The Academy for Educational Development’s 
recommend the following (CDC, 2006): 
• Amend the drug paraphernalia law to exclude syringes; 
 
• Amend the controlled drug act to require a minimum specified quantity to 
ground a possession conviction; 
 
• Amend the controlled drug act to exclude trace amounts found in syringes; 
 
• Develop standard operating procedures within law enforcement that avoid 
stops, arrests or prosecutions based on drug residues in syringes; and 
 
• Educate IDUs and law enforcement to appreciate the importance of appropriate 
syringe services and the legality of possessing syringes in the course of 
disposal activities. 
 
Considering these recommendations would be an initial step to decrease the barrier to 
accessing services for clean syringes and works in Montana. In addition, examining the 
policies of states that have successfully implemented needle exchange programs may be a 
starting point for Montana.  In December 2006 New Jersey adopted a needle exchange 
program policy.  A copy of the legislative document (Appendix G) could serve as a 
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model for Montanans to research and review. 
Research strategic options and formulate a plan for securing additional funding for 
substance abuse treatment, Hepatitis C services and coordinated HIV prevention 
efforts. 
 Securing funds for any service is a huge undertaking.  It is evident from this 
assessment that more funding is needed to provide services to those who need it in 
Montana.  Collaborating with substance abuse treatment agencies to secure funding for 
both substance abuse treatment and HIV/Hepatitis C services together would increase 
available funds in Montana for these services. 
 One specific example of possible funding is the SAMHSA Targeted Capacity 
Expansion for Substance Abuse Treatment and HIV/AIDS Services (TCE/HIV).  The 
purpose of the TCE/HIV grant program is to enhance and expand substance abuse 
treatment and/or outreach and pretreatment services in conjunction with HIV/AIDS 
services.  This grant funding opportunity is open to domestic private/public nonprofit 
entities, public or private universities and colleges, and community and faith-based 
organizations.  The targeted publication date for the request for proposals is Fall 2007.  
Opportunities such as this may provide not only additional funding for the state but also 
an occasion for agency networking.  Information regarding this funding is available at: 
http://www.samhsa.gov/Grants/2007/fy2007opps.aspx. 
Ensure continued HIV prevention information dissemination through media 
campaigns and other educational interventions. 
 Participants talked candidly and at length about the importance of disseminating 
HIV prevention information that is accurate, detailed and non-judgmental.  Several 
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participants suggested creating documentaries about people who are dealing with 
substance abuse problems and living with HIV and Hepatitis C.  IDU participants in this 
study perceived the current “Not Even Once” methamphetamine campaign as creating 
even more stigma and discrimination for IDUs, and creating greater barriers to accessing 
treatment and services.   
 Media campaigns have the capability of addressing predisposing, reinforcing and 
enabling factors while decreasing the barriers to accessing services for IDUs.  It is 
important that Montana continue its current HIV prevention media campaign.  This 
campaign, although limited in scope, targets IDUs with accurate prevention messages in a 
non-judgmental and humane way.  Expanding this campaign with an increased focus on 
the IDU population could serve a multipurpose in eliminating stigma and discrimination, 
educating target populations and the general public on HIV, and ultimately helping to 
reduce HIV and Hepatitis C infection in Montana. 
Ensure continued harm reduction services. 
 Continuing to provide current harm reduction strategies such as educational 
outreach, free HIV counseling and testing, and access and referrals to social service 
agencies throughout Montana is an important component in HIV prevention.  Educational 
outreach should include strategies that focus on the predisposing, reinforcing and 
enabling factors identified in this study such as knowledge, self-esteem building and 
readiness to change behavior.  Social outlets and alternatives to substance use that include 
HIV and Hepatitis C education and information should be considered for harm reduction 
strategies.  Not only do these services provide access to the target population, they also 
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provide IDUs with the opportunity to engage socially and to take full advantage of HIV 
prevention efforts here in Montana.   
CONCLUSIONS 
 Everyone who reads this report and cares about the welfare of IDUs in Montana 
will draw their own conclusions about where the greatest needs lie.  The preponderance 
of evidence from this research project, however, points to the fact that access to clean 
needles is a priority need for IDUs in Montana.  Research has demonstrated that access to 
clean needles is an effective intervention for both HIV and Hepatitis C prevention (CDC, 
2006), and yet this service is not available in Montana.  It is imperative that this service 
be looked into as an HIV prevention measure.  A related issue that cannot be ignored is 
the fact that approximately 60 percent of IDUs acquire Hepatitis C within their first year 
of use (CDC, 2006). Unfortunately, few resources for Hepatitis C prevention are 
available here.  Thus, it seems logical and efficacious that HIV prevention interventions, 
like access to clean needles, also address the Hepatitis C epidemic in Montana.   
 In addition to access to clean needles and Hepatitis C prevention, other 
recommendations are important and need to be considered.   First, efforts to eliminate 
stigma and discrimination faced by people who use injection drugs should be a part of all 
prevention strategies.  Second, individuals who are ready to seek help for substance abuse 
problems should have access to treatment services.  And finally, we should continue to 
provide free HIV testing and HIV prevention education in addition to considering other 
interventions such as alternative social outlets that can further the efforts of HIV 
prevention.   
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  In view of all of the recommendations that emerged from this study, organizing a 
coalition for HIV prevention in Montana seems to umbrella all facets.  Collaborating with 
other service agencies to provide valuable services and joining forces with substance 
abuse treatment programs to secure additional funding can improve HIV prevention 
efforts in Montana.  Under the umbrella of a coalition, policy issues can be researched 
and community involvement can be obtained to maximize efforts.   
 Some of these strategies may seem out of reach to Montanans.  However a 
comprehensive prevention plan is crucial to optimize HIV prevention among IDUs.  With 
diligent work and collaboration, these interventions are possible. 
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Appendix B 
IDU Participant Interview Questions 
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IDU Participant Interview Schedule 
 
Date/Time of Interview:  
 
Place of Interview: 
 
ID/Name:  
 
Age: 
  
Gender (sexual identity):  
 
Employment/Education  
What kind of work do you do? 
How much do you make?  
How much education do you have?  
 
Geographical Information 
Where do you currently live? 
Where did you grow up? 
Moves/geographical cures:  
How did these moves influence your drug use? 
 
Drug Use  
Age of first drug use: ______________________ 
Number of years used: _____________________ 
Currently using? __________________________ 
Using at time of interview? __________________ 
Date of first injection: ______________________ 
Date of last injection: ______________________ 
Drug of choice: ___________________________ 
Modes of administration:  
Other drugs used: 
Treatments for drug use if any:  
How do/did you pay for your drugs? 
Have you ever been assaulted while high or because of drug use? 
Are there children around when you use? 
Why did you start using? Reason(s) for onset of drug use:  
What factors do you believe have influenced your use?  
What did you learn in your youth about drug use? (DARE, Just Say No, etc.) 
In retrospect, what reasons/factors may have prevented your first use? 
 
HIV Information 
What do you know about HIV infection? 
What/how have you been taught about HIV? (School, family, friends, etc.) 
What behaviors have you engaged in that you believe have put you at risk for HIV 
infection? 
Factors that contribute to engaging in behaviors that increase HIV infection risk: 
Behaviors: 
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Service, Assistance and Treatment 
What do you think are the greatest assistance and/or treatment needs of IDUs?  
What types of assistance and/or treatment services that IDUs in Montana need but aren’t 
getting? 
How satisfied do you think IDUs in Montana are with current assistance and/or treatment  
services?  
 
Barriers 
What barriers do you see IDUs face in regards to accessing assistance and/or services? 
What barriers do you see IDUs face in regards to decreasing or discontinuing using 
drugs? 
  
What are the best ways to reach IDUs in Montana who are not currently being 
served? 
 
What other thoughts do you have regarding the needs of IDUs in Montana? 
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Key Informant Interview Questions 
 
1.  What are the greatest HIV prevention assistance and/or treatment needs of 
IDUs? 
 
2.  What types of HIV prevention assistance and/or services that IDUs in 
Montana need but aren’t getting? 
 
3.  How satisfied do you think IDUs in Montana are with assistance and/or 
treatment services?  
 
4.  What barriers do you see IDUs face in regards to accessing assistance and/or 
services? 
 Structural barriers? 
 
 Organizational barriers? 
 
 Cultural barriers? 
 
 Individual barriers, such as knowledge, physical or mental well-being, 
community, etc.? 
  
5.  What barriers do you see IDUs face in regards to decreasing or discontinuing 
using drugs? 
 Structural barriers? 
 
 Organizational barriers? 
 
 Cultural barriers? 
 
 Individual barriers, such as knowledge, physical or mental well-being, 
community, etc.? 
 
6.  What are the best ways to reach IDUs in Montana who are not currently being 
served? 
 
7.  What other thoughts do you have regarding the needs of IDUs in Montana? 
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Contact Summary Sheet 
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CONTACT SUMMARY SHEET 
 
Date ___________     Interview Length _______ 
Interview No. _____     Interview Location ___________ 
 
 
1. Physical description/impressions. 
 
 
 
 
 
 
2. Main themes and issues. 
 
 
 
 
 
 
 
3. Research question most directly addressed. 
 
 
 
 
 
4. New working hypothesis or speculations. 
 
 
 
 
 
5. Problems or questions. 
 
 
 
 
 
6. Direction of information needed for next interview. 
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Appendix E 
Regional Map of Montana 
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MONTANA – Substate Regions (defined in terms of counties) 
 
The substate regions defined here were provided by the Chemical Dependency Bureau of 
the Montana Department of Health and Human Services and are defined in terms of the 
State's 57 counties. 
Region 1 Region 2 Region 3 Region 4 Region 5 
Carter 
Custer 
Daniels 
Dawson 
Fallon 
Garfield 
McCone 
Phillips 
Powder River 
Prairie 
Richland 
Roosevelt 
Rosebud 
Sheridan 
Treasure 
Valley 
Wibaux 
Blaine 
Cascade 
Chouteau 
Glacier 
Hill 
Liberty 
Pondera 
Teton 
Toole 
Big Horn 
Carbon 
Fergus 
Golden Valley 
Judith Basin 
Musselshell 
Petroleum 
Stillwater 
Sweet Grass 
Wheatland 
Yellowstone 
Beaverhead 
Broadwater 
Deer Lodge 
Gallatin 
Granite 
Jefferson 
Lewis and Clark 
Madison 
Meagher 
Park 
Powell 
Silver Bow 
Flathead 
Lake 
Lincoln 
Mineral 
Missoula 
Ravalli 
Sanders 
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Appendix F 
State Approved Chemical Dependency Treatment Programs
 108
State Approved Chemical Dependency Program Listing By City 
Western MT Addictions Services Alcoholism 
Services of Anaconda-Deer Lodge 118 E 7th 
Ste 2E Anaconda MT 59711-0758  
Don Simpson Office 
Manager  
258  
Phone 1: (406) 563-6601  
Phone 2: (406) 563-5248  
Fax: (406) 563-7719  
Crisis Phone:  
Email: 
dsimpson@montana.com  
Email 2: Website:  
Services: Outpatient I & Outpatient II, Act, MIP   
Office Hours:  County: Deer Lodge  
 
EMCMHC - Substance Abuse/Dependency 
Svcs  
Baker Satellite Office Fallon County Courthouse 
Baker MT 59313  
John Rex  273  
Phone 1: (406) 232-1687 (Miles City)  
Phone 2:  
Fax:  
Crisis Phone:  
Email: 
rex_john@hotmail.com 
Email 2: Website:  
Services: Outpatient & ACT   
Office Hours: Tuesday  County: Fallon  
 
South Central Regional Mental Health Center 
(SCMRMHC) Journey Recovery Program  
P.O. Box 236  
Big Timber MT 59011  
Colleen O'Connor  206  
Phone 1: (406) 932-5145  
Phone 2:  
Fax: (406) 932-5924  
Crisis Phone:  
Email: Email 2: 
Website:  
Services: Outpatient & ACT   
Office Hours: Tuesday & Wednesday  County: Sweet Grass  
 
Rimrock Foundation  
1231 North 29th Street P.O. Box 30374  
Billings MT 59101  
Mona Sumner COO 
(Chief Operations 
Officer)  
202  
Phone 1: (406) 248-3175  
Phone 2: 1-800-227-3953 
 Fax: (406) 248-3821  
Crisis Phone:  
Email: 
monasumner@aol.com 
Email 2: Website: 
www.rimrock.org  
Services: Detox (12 bed), Inpatient free-standing (45 bed), Outpatient, IOP, 
Day Txt & ACT  
Office Hours:  County: Yellowstone  
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New Choices  
Rimrock Foundation  
1220 Poly  
Billings MT 59102  
Coralee Goni,  
Adol Services Coor  
202  
Phone 1: (406) 248-3175  
Phone 2: 1-800-227-3953  
Fax: (406) 248-3821  
Crisis Phone:  
Email: Email 2: 
Website: 
www.rimrock.org  
 Services: Adolescent Program  
Office Hours: M-F, 8-5  County: Yellowstone  
 
South Central Regional Mental Health Center 
(SCMRMHC) Journey Recovery Program  
201 N 25th Street  
Billings MT 59101  
Dot Reichert 
Coordinator  
206  
Phone 1: (406) 254-1314  
Phone 2:  
Fax: (406) 254-1650  
Crisis Phone:  
Email: dor@vcn.com 
Email 2: Website:  
Services: Outpatient, IOP & ACT   
Office Hours: Monday - Friday  County: Yellowstone  
 
Indian Health Board of Billings  
1127 Alderson Ave  
Billings MT 59102  
Marjorie Bear Don’t 
Walk Exe Director  
277  
Phone 1: (406) 245-7318  
Phone 2: (406) 259-3920  
Fax: (406) 248-5912  
Crisis Phone:  
Email: Email 2: 
Website:  
Services: Outpatient, IOP, Continuing Care   
Office Hours:  County: Yellowstone  
 
Boyd Andrew Community Services  
Boulder Satellite Office  
Human Services Building  
P.O. Box H  
Boulder MT 59632  
Ron Napierala  222  
Phone 1: (406) 225-4071  
Phone 2: (406) 443-2343  
Fax:  
Crisis Phone:  
Email: 
rnapierala@boydandrew.c
om Email 2: Website: 
www.boydandew.com  
Services: Outpatient & ACT   
Office Hours: Tue, 1:00 - 4:00  County: Jefferson  
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Alcohol & Drug Services of Gallatin Co.  
502 South 19th Avenue - Ste 302  
Bozeman MT 59718-6827  
Shelly Johnson Director  201  
Phone 1: (406) 586-5493  
Phone 2:  
Fax: (406) 587-1238  
Crisis Phone:  
Email: adsgc@imt.net 
Email 2: Website:  
Services: Outpatient, IOP, ACT and Continuing Care - Recovery Home 
(transitional living)  
Office Hours:  County: Gallatin  
   
EMCMHC - Substance Abuse/Dependency 
Svcs  
Broadus Satellite Office  
Power River County Courthouse  
Broadus MT 59317  
Rafael Zarsosa  273  
Phone 1: (406) 232-1687 (Miles City)  
Phone 2:  
Fax:  
Email: Email 2: Website: 
Crisis Phone:  
 Services: Outpatient & ACT  
Office Hours: Thur  County: Powder River  
 
Crystal Creek Lodge  
P.O. Box 450  
Browning MT 59417  
Pat Calf Looking Director  212  
Phone 1: (406) 338-6330  
Phone 2:  
Fax: (406) 338-7660  
Crisis Phone:  
Email: 
calf_looking@hotmail.com 
Email 2: Website:  
Services: Inpatient Free Standing & ACT   
Office Hours: Mon-Fri, 8:00 a..m. - 5:00 p.m.  County: Glacier  
 
TLC Recovery, Inc  
CHR Building (Old Welfare)  
Browning MT 59417  
 259  
Phone 1: (406) 873-2155 (Cut Bank) 
Phone 2: (406) 338-7808 Fax: Crisis 
Phone:  
Email: tlccarol@ttc-cmc.net Email 
2: 
georgeanne59442@yahoo.com 
Website:  
Services: Outpatient & ACT   
Office Hours: Wednesday  County: Glacier  
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Montana Chemical Dependency Center 
2500 Continental Drive  
Butte MT 59701  
Dave Peshek  
Administrator  
223  
Phone 1: (406) 496-5400  
Phone 2: 
 Fax: (406) 496-5437  
Crisis Phone:  
Email: dpeshek@mt.gov 
Email 2: Website:  
Services: Inpatient Free-Standing (76 beds), Detox, Co-Occuring Distorders 
Treatment  
Office Hours:  County: Silver Bow  
 
Butte-Silver Bow Chemical 
Dependency Services  
25 West Front Street  
Butte MT 59701-9213  
Ralph Boerner  
Director  
234  
Phone 1: (406) 497-5070  
Phone 2: Fax: (406) 497-5063 
Crisis Phone:  
Email: chemicaldependency@in-
tch.com Email 2: Website:  
Services: Outpatient, IOP & ACT   
Office Hours: Mon-Fri, 8:00 a..m. - 
5:00 p.m.  County: Silver Bow  
 
TLC Recovery, Inc  
Courthouse  
Chester MT 59522  
Mailing Address:  
P.O. Box 459  
Fort Benton, MT 59442  
 259  
Phone 1: (406) 759-5615 Phone 2: (406) 
622-3211 Fax: (406) 622-5141 Crisis 
Phone:  
Email: tlccarol@ttc-cmc.net 
Email 2: 
georgeanne59442@yahoo.
com Website:  
Services: Outpatient & ACT   
Office Hours: Tuesday  County: Liberty  
 
TLC Recovery, Inc  
Courthouse  
Chinook MT 59523  
Mailing Address: P.O. Box 459  
Fort Benton, MT 59442  
 259  
Phone 1: (406) 262-9299 
Phone 2:  
Fax:  
Crisis Phone:  
Email: tlccarol@ttc-cmc.net  
Email 2: 
georgeanne59442@yahoo.com 
Website:  
Services: Outpatient & ACT   
Office Hours: Tuesday  County: Blaine  
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Golden Triangle - Teton County  
19 3rd St NE  
P.O. Box 1139  
Choteau MT 59422  
Nancy Semenza, 
Counselor  
283  
Phone 1: (406) 466- 5681  
Phone 2:  
Fax: (406) 466- 5683  
Crisis Phone:  
Email:  
Email 2: Website:  
Services: Outpatient & ACT   
Office Hours: Tue, Wed and Thursday a.m.  County: Teton  
Notes: Do not have mail delivery at street address.  
 
EMCMHC - Substance Abuse/Dependency 
Svcs  
Colstrip Satellite Office  
417 Willow P.O. Box 750  
Colstrip MT 59323-0750  
Karla McDonald  273  
Phone 1: (406) 748-2800  
Phone 2:  
Fax:  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient & ACT   
Office Hours: Thur & Fri  County: Rosebud  
 
 
Flathead Valley Chemcial Dependency Clinic 
North Valley Office  
110 Nucleus Avenue Ste B  
P.O. Box 2418  
Columbia Falls MT 59912  
Patty Morrison  209  
Phone 1: (406) 892-7900  
Phone 2:  
Fax:  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient, IOP & ACT   
Office Hours: Monday - Friday  County: Flathead  
 
South Central Regional Mental Health Center 
(SCMRMHC) Journey Recovery Program  
410 East Pike P.O. Box 238  
Columbus MT 59019-0238  
Colleen O'Connor  206  
Phone 1: (406) 322-4514  
Phone 2:  
Fax: (406) 322-4515  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient   
Office Hours: Monday  County: Stillwater  
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TLC Recovery, Inc  
809 Sunset Blvd  
Conrad MT 59425  
 259  
Phone 1: (406) 278-5245  
Phone 2:  
Fax:  
Crisis Phone:  
Email: tlccarol@ttc-cmc.net  
Email 2: 
georgeanne59442@yahoo.com 
Website:  
Services: Outpatient & ACT   
Office Hours: Thursday  County: Pondera  
 
TLC Recovery, Inc  
1210 E Main St - Courthouse Annex 
P.O. Box 696  
Cut Bank MT 59427-0608  
Patty Geer Office Manager  259  
Phone 1: (406) 873-2155  
Phone 2:  
Fax: (406) 873-2155  
Crisis Phone:  
Email:  
Email 2: 
georgeanne59442@yahoo.com 
Website:  
Services: Outpatient & ACT   
Office Hours: Tuesday  County: Glacier  
 
 
Don Simpson Office 
Manager  
Western MT Addiction Services  
Powell County Satellite Office  
304 Milwaukee - Ste 27 P.O. Box 147 
Deer Lodge MT 59722-0147  
258  
Phone 1: (406) 846-3442  
Phone 2:  
Fax: (406) 846-1596  
Crisis Phone:  
Email: 
dsimpson@wmmhc.org  
Email 2:  
Website:  
Services: Outpatient & ACT, MIP, Adult & Adol 
Services  
 
Office Hours: 9:00 a.m. - 5:00 p.m. - Mon - 
Thur -Services hours in evening.  
County: Powell  
 
Treasure State Correctional Training 
Center  
1100 Conley Lake Road  
Deer Lodge MT 59722  
Dan Burden Prgm Manager  270  
Phone 1: (406) 846-1320 X 2110  
Phone 2:  
Fax: (406) 846-2969  
Crisis Phone:  
Email: theaton@state.mt.us 
Email 2:  
Website:  
Services: Outpatient   
Office Hours:  County: Powell  
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Montana State Prison CD Program  
500 Conley Lake Road  
Deer Lodge MT 59722-9755  
Blair Hopkins Program 
Director  
271  
Phone 1: (406) 846-1320 x 2225  
Phone 2:  
Fax: (406) 846-2951  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient   
Office Hours:  County: Powell  
 
Southwest C D Program  
Beaverhead County  
38 North Atlanta P.O. Box 527  
Dillon MT 59725  
Dave Blodget LAC  231  
Phone 1: (406) 683-4305  
Phone 2:  
Fax: (406) 683-9767  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient & ACT   
Office Hours: Monday - Friday  County: Beaverhead  
 
 
Southwest C D Program  
Madison County Satellite  
FNI Building P.O. Box 896  
Ennis MT 59729  
Bob Clarkson LAC  231  
Phone 1: (406) 682-7190  
Phone 2:  
Fax: (406) 683-9767  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient & ACT   
Office Hours: 1st, 2nd & 3rd Thur  County: Madison  
 
FVCD - Eureka Office  
North Lincoln County Annex  
P.O.Box 1409  
Eureka MT 59914  
Rick James Couslor  209  
Phone 1: (406) 296-2822  
Phone 2:  
Fax: (406) 296-2822  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient, Act   
Office Hours: Monday-Friday  County: Lincoln  
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EMCMHC - Substance Abuse/Dependency 
Svcs  
Forsyth Satellite Office  
1093 Main Street P.O. Box 1257  
Forsyth MT 59327  
Jan Frederick  273  
Phone 1: (406) 346-7654  
Phone 2:  
Fax:  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient & ACT   
Office Hours: Wed  County: Rosebud  
 
TLC Recovery, Inc  
Courthouse Annex P.O. Box 459 
 Fort Benton MT 59442  
Carol Richard Director  259  
Phone 1: (406) 622-3211  
Phone 2:  
Fax: (406) 622-5141  
Crisis Phone:  
Email: tlccarol@ttc-cmc.net 
Email 2: 
georgeanne59442@yahoo.co
m Website:  
Services: Outpatient & ACT   
Office Hours: Mon - Fri  County: Choteau  
 
EMCMHC - Substance Abuse/Dependency 
Svcs  
Glasgow Satellite Office  
Deborah Knox  
1009 6th Avenue N  
Glasgow MT 59230-1626  
273  
Phone 1: (406) 228-9349  
Phone 2:  
Fax:  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient & ACT   
Office Hours:  County: Valley  
 
District II Alcohol & Drug Program  
119 South Kendrick  
Glendive MT 59330  
Jerry Schlepp Director  211  
Phone 1: (406) 377-5942  
Phone 2:  
Fax: (406) 377-3050  
Crisis Phone:  
Email: 
distii@midrivers.com 
Email 2:  
Website:  
Services: Outpatient, IOP. ACT, MIP   
Office Hours: Mon-Fri, 8a - 5p or as scheduled  County: Dawson  
 
 
 116
Gateway Community Services  
401 3rd Ave North  
Great Falls MT 59401-2496  
Judy Kolar Director  227  
Phone 1: (406) 727-2512 
 Phone 2:  
Fax: (406) 727-7451  
Crisis Phone:  
Email: 
judy@gatewayrecovery.or
g Email 2:  
Website: 
www.gatewayrecovery.org 
Services: Outpatient, IOP & ACT   
Office Hours: Mon-Thur 8a.m .-8p.m. / Fri 8a.m. -
5p.m.  
County: Cascade  
 
Grace Home  
2211 5th Ave North  
Great Falls MT 59401  
 227  
Phone 1: (406) 452-6655  
Phone 2:  
Fax: (406) 452-6561  
Crisis Phone:  
Email:  
Email 2:  
Website: www.gatewayrecovery.org  
Services: Transitional Living - Women 
& Children  
 
Office Hours:  County: Cascade  
 
Benefis Healthcare Behavioral Health 
Services  
500 15th Avenue South  
Great Falls MT 59405-5193  
Marlene O'Connell, RN, 
MSW Manager  
247  
Phone 1: (406) 455-2367  
Phone 2:  
Fax: (406) 455-2373  
Crisis Phone:  
Email: 
oconmara@benefis.org 
Email 2:  
Website: 
www.benefis.org  
Services: Inpatient Hospital (20 Beds) & ACT, Partial Hospitalization; 
Outpatient. Detox  
Office Hours:  County: Cascade  
 
Rocky Mountain Txt Center, Inc.  
920 4th Ave North  
Great Falls MT 59401-4199  
 248  
Phone 1: (406) 727-8832  
Phone 2: 1-800-521-6572  
Fax: (406) 727-8172  
Crisis Phone:  
Email: rmtc@att.net 
Email 2: Website: 
www.RMTC-
Care.com  
Services: Inpatient Free-Standing (28 
beds), Day Treatment  
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Western MT Addiction Services Ravalli Co. 
209 N 10th St, Ste. #C P.O. Box 902  
Hamilton MT 59840-0902  
Jim Mason Office 
Manager  
258  
Phone 1: (406) 532-9140  
Phone 2:  
Fax: (406) 363-3061  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient, IOP, ACT, MIP   
Office Hours: 8:00 a.m. - 5:00 p.m. - Services 
hours in evening  
County: Ravalli  
 
South Central Regional Mental Health 
Center (SCMRMHC)  
Journey Recovery Program  
Dean Big Horn  
809 North Custer  
Hardin MT 59034-1311  
206  
Phone 1: (406) 665-8730  
Phone 2:  
Fax: (406) 665-8755  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient & ACT   
Office Hours: Tuesday & Thursday  County: Big Horn  
 
TLC Recovery, Inc  
City Hall P.O. Box 579  
Harlem MT 59526  
 259  
Email: tlccarol@ttc-cmc.net  Phone 1: (406) 262-9299  
Phone 2:  
Fax: (406) 265-1071  
Crisis Phone:  
Email 2: 
georgeanne59442@yahoo.com 
Website:  
Services: Outpatient & ACT   
Office Hours: Wednesday  County: Blaine  
 
TLC Recovery, Inc  
Courthouse Annex  
314 4th Ave  
Havre MT 59501  
 259  
Phone 1: (406) 262-9299  
Phone 2:  
Fax: (406) 265-1071  
Crisis Phone:  
Email: tlccarol@ttc-cmc.net 
Email 2: 
georgeanne59442@yahoo.co
m Website:  
Services: Outpatient & ACT   
Office Hours: Mon-Fri  County: Hill  
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Boyd Andrew Community Services  
The Arcade Building - Ste 1E  
P.O. Box 1153  
Helena MT 59624-1153  
Mike Ruppert CEO  222  
Phone 1: (406) 443-2343  
Phone 2:  
Fax: (406) 443-5490  
Crisis Phone:  
Email: 
dblock@boydandrew.com 
Email 2:  
Website: 
www.boydandew.com  
Services: Outpatient, IOP & ACT   
Office Hours: Mon-Fri, 8:00 a..m. - 5:00 p.m.  County: Lewis & Clark  
 
Boyd Andrew Community Services 
Transitional Living Facility for Men  
410 9th Ave  
Helena MT 59601-3721  
Sandy Jones  222  
Phone 1: (406) 443-1241  
Phone 2: (406) 443-2343  
Fax: (406) 443-1241  
Crisis Phone:  
Email: 
sjones@boydandrew.com 
Email 2:  
Website: 
www.boydandew.com  
Services: Intermediate Care (Transitional Living 7 bed for men)  
Office Hours: Mon-Fri, 8:00 a..m. - 5:00 p.m.  County: Lewis & Clark  
 
Mike Cummins Director  Flathead Valley Chemcial Dependency 
Clinic  
1312 North Meridian  
P.O. Box 7115  
Kalispell MT 59904-0115  
209  
Phone 1: (406) 756-6453  
Phone 2:  
Fax: (406) 756-8546  
Crisis Phone:  
Email: 
fmichaelcummins@fvdc.n
et Email 2: 
 Website:  
Services: Outpatient, IOP & ACT   
Office Hours: Monday-Friday  County: Flathead  
 
Pathways Treatment Center  
200 Heritage Way  
Kalispell MT 59901-3180  
Leslie Nyman Interim 
Manager  
274  
Phone 1: (406) 756-3950 xt 6403  
Phone 2:  
Fax: (406) 756-3957  
Crisis Phone:  
Email: lnyman@krmc.org 
Email 2:  
Website:  
Services: Inpatient Hospital (40 beds) and Day 
Treatment  
 
Office Hours:  County: Flathead  
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Lance Eller  South Central Regional Mental Health Center 
(SCMRMHC)  
Journey Recovery Program  
212 Wendell P.O. Box 44  
Lewistown MT 59457  
206  
Phone 1: (406) 538-7483  
Phone 2:  
Fax: (406) 538-7491  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient, IOP & ACT For services in Stanford and Harlowton, 
please call the Lewistown office.  
Office Hours: Mon - Fri, 8a.m. to 5p.m.  County: Fergus  
 
Flathead Valley Chemcial Dependency 
Clinic  
101 Woodland Road  
P.O. Box 756  
Libby MT 59923  
Mark Clark Coordinator  209  
Phone 1: (406) 293-7731  
Phone 2:  
Fax: (406) 293-8530  
Crisis Phone:  
Email: 
fvcdcmark@frontiernet.ne
t Email 2:  
Website:  
Services: Outpatient, IOP & ACT   
Office Hours: Monday-Friday  County: Lincoln  
 
Southwest C D Program 
 430 East Park  
Jean McCauley Program 
Director  
P.O. Box 1587  
Livingston MT 59047-2746  
231  
Phone 1: (406) 222-2812  
Phone 2:  
Fax: (406) 222-4764  
Crisis Phone:  
Email: swcdp@aol.com 
Email 2:  
Website:  
Services: Outpatient, IOP & ACT - Recovery House (transitional living)  
Office Hours: Monday - Friday  County: Park  
 
EMCMHC - Substance Abuse/Dependency 
Svcs  
Malta Satellite Office  
1009 6th Ave North  
Malta MT 59230  
Deborah Knox  273  
Phone 1: (406) 228-9349 (Glasgow)  
Phone 2:  
Fax:  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services:   
Office Hours: Mon  County: Phillips  
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Wilderness Treatment Center  
200 Hubbart Dam Road  
Marion MT 59925-9708  
John Brekke Director  250  
Phone 1: (406) 854-2832  
Phone 2:  
Fax: (406) 854-2835  
Crisis Phone:  
Email: wtc@digisys.net  
Email 2:  
Website: 
www.wildernesstreatmentcentr.co
m  
Services: Inpatient - Free Standing (35 
beds)  
 
Office Hours: 8:00 a.m. - 5:00 p.m.  County: Flathead  
 
Alternative Youth Services Center Inc. 
4880 US Hywy 93 S  
Kalispell MT 59901-7985  
Richard Balas Director  275  
Email:  Phone 1: (406) 857-2506  
Email 2:  Phone 2:  
Fax: (406) 857-2503  
Crisis Phone:  
Website: www.aycare.com  
Services: Juvenile Transitional Living 
Facility  
 
Office Hours:  County: Flathead  
 
EMCMHC - Substance 
Abuse/Dependency Svcs  
2508 Wilson P.O. Box 1530  
Miles City MT 59301  
John Rex Program Director  273  
Phone 1: (406) 234-1687 (Clinic)  
(406) 234-0235 (Office)  
Phone 2: 1-800-597-6604  
Fax: (406) 234-1698 (Clinic)  
Crisis Phone:  
Email: rex_john@hotmail.com 
Email 2:  
Website:  
Services: Outpatient, IOP & ACT   
Office Hours:  County: Custer  
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Missoula Indian Center  
Bldg 33, Fort Missoula Rd  
P.O. Box 16927  
Missoula MT 59808  
Steve Lohning Clinical 
Supervisor  
224  
Phone 1: (406) 721-2700  
Phone 2: (406) 829-9151 or 9516 
Fax: (406) 829-9519  
Crisis Phone: 24 Hour –  
(406) 721-2700  
Email: slohning@montana.com 
Email 2:  
Website:  
Services: Outpatient, IOP, MIP, Assessments/Evaluations, Adolescent & 
Family Txt  
Office Hours: Mon-Fri 8 a.m. - 5 p.m.  County: Missoula  
 
St. Patrick Hospital –  
ATP 500 West Broadway  
P.O. Box 4587  
Missoula MT 59806-4587  
Linda Bradford Director  254  
Phone 1: (406) 327-3020  
Phone 2:  
Fax: (406) 327-3500  
Crisis Phone:  
Email: 
bradford@saintpatrick.org 
Email 2:  
Website:  
Services: Inpatient Hospital (18 beds) - IOP Adults/Adolescents  
Office Hours:  County: Missoula  
 
Western Montana Addiction Services 
Turning Point  
1325 Wyoming  
Missoula MT 59801  
Emery Jones Acting 
Director  
258  
Phone 1: (406) 532-9800  
Phone 2:  
Fax: (406) 541-3032  
Crisis Phone:  
Email: 
ejones@wmmhc.org 
Email 2:  
Website:  
Services: Outpatient, IOP, Adult & Adol Svcs - 
ACT, MIP  
 
Office Hours: 8:30 a.m. - 8:30 p.m. - Mon - Thur -
Services hours in evening  
County: Missoula  
 
Share House  
1330 S 4th Street West  
Missoula MT 59801  
Sue Rajacich Program 
Director  
258  
Phone 1: (406) 532-9830  
Phone 2:  
Fax: (406) 541-3031  
Crisis Phone:  
Email: 
srajacich@wmmhc.org 
Email 2:  
Website:  
Services: Transitional Living - Men & Woman / 
Detox  
 
Office Hours: 24 Hour  County: Missoula  
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Carol Graham Home  
1335 Wyoming  
Missoula MT 59802  
Sue Rajacich Program 
Director  
258  
Phone 1: (406) 549-8309  
Phone 2:  
Fax: (406) 541-3031  
Crisis Phone:  
Email: 
srajacich@wmmhc.org 
Email 2:  
Website:  
Services: Transitional Living - Women & Children   
Office Hours: 9:00 - 4:00 p.m.  County: Missoula  
 
EMCMHC - Substance Abuse/Dependency 
Svcs  
Plentywood Satellite Office  
Sheridan County Courthouse  
Plentywood MT 59254  
Anita Plann  273  
Phone 1: (406) 765-2550  
Phone 2:  
Fax:  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient & ACT   
Office Hours:  County: Sheridan  
 
Lake County Chemical Dependency 
Program  
802 Main Street - Ste C  
Polson MT 59860-3200  
Theresa Oakland 
Director  
251  
Phone 1: (406) 883-7310  
Phone 2:  
Fax: (406) 883-7312  
Crisis Phone:  
Email: 
toakland@lakemt.gov 
Email 2: Website: 
www.lakecounty-mt.org  
Services: Outpatient, IOP, & ACT, & Adol Svc   
Office Hours: 8:00 a.m. - 5:00 p.m.  County: Lake  
 
Jack Cummins  South Central Regional Mental Health Center 
(SCMRMHC)  
Journey Recovery Program  
5 East 9th Street  
P.O. Box 482  
Red Lodge MT 59068-0482  
206  
Phone 1: (406) 446-2500  
Phone 2:  
Fax: (406) 446-2501  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient, IOP & ACT   
Office Hours: Monday - Friday  County: Carbon  
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South Central Regional Mental Health Center 
(SCMRMHC)  
Journey Recovery Program  
26 W Main Street  
Roundup MT 59072  
Del Denton  206  
Phone 1: (406) 323-1142  Email:  
Phone 2:  Email 2:  
Fax: (406) 323-1149  
Crisis Phone:  
Website:  
Services: Outpatient & ACT   
Office Hours: Tuesday & Wednesday  County: Musselshell  
 
EMCMHC - Substance Abuse/Dependency 
Svcs  
Anita Plann  
Scobey Satellite Office  
Daniels County Courthouse  
Scobey MT 59263  
Mailing Address:  
1009 6th Ave N  
Glasgow MT 59230-1626  
273  
Phone 1: (406) 228-9349 (Glasgow)  
Phone 2:  
Fax:  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient   
Office Hours: Thu  County: Daniels  
Notes: Do Not Send Mail To The Scobey Office.   
 
TLC Recovery, Inc  
Adult Probation Building  
Shelby MT 59474  
 259  
Phone 1: (406) 460-0771  
Phone 2:  
Fax:  
Crisis Phone:  
Email: tlccarol@ttc-cmc.net 
Email 2: 
georgeanne59442@yahoo.com 
Website:  
Services: Outpatient & ACT   
Office Hours: Wednesday  County: Toole  
 
Tim Anderson  District II Alcohol & Drug Program  
Sidney Alcohol Satellite  
209 2nd Street SE  
Sidney MT 59270  
211  
Email: 
adsidney@midrivers.com 
Email 2:  
Phone 1: (406) 433-4097  
Phone 2:  
Fax: (406) 433-4726  
Crisis Phone:  Website:  
Services: Outpatient, IOP, ACT, MIP   
Office Hours: Mon-Fri, 8a - 5p or as scheduled  County: Richland  
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Western MT Addiction Services  
305 Main West  
P.O. Box 745  
Superior MT 59872  
Pam Strong Counselor  258  
Phone 1: (406) 822-4093  
Phone 2:  
Fax: (406) 822-3077  
Crisis Phone:  
Email: 
JMC2630@aol.com  
Email 2:  
Website:  
Services: Outpatient & ACT, MIP   
Office Hours:  County: Mineral  
 
FVCD - Thompson Falls Office  
301 Main #4 P.O. Box 940  
Thompson Falls MT 59873  
Christine Nowark 
Couslor  
209  
Phone 1: (406) 827-4241  
Phone 2:  
Fax: (406) 827-9677  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient, Act   
Office Hours: Monday-Friday  County: Sanders  
 
Boyd Andrew Community Services 
Broadwater County Alcohol Services  
122 Broadway P.O. Box 52  
Townsend MT 59644  
Sandy Jones  222  
Phone 1: (406) 266-4358  
Phone 2: (406) 443-2343  
Fax:  
Crisis Phone:  
Email: 
sjones@boydandrew.com 
Email 2:  
Website: 
www.boydandew.com  
Services: Outpatient & Act   
Office Hours: Monday, 8:30 a.m. - 4:00 p.m.  County: Broadwater  
 
Southwest C D Program  
Meagher County Satellite  
P.O. Box 474  
White Sulphur Springs MT 59645-0474  
Vera Towery LAC  231  
Phone 1: (406) 547-2249  
Phone 2:  
Fax:  
Crisis Phone:  
Email:  
Email 2:  
Website:  
Services: Outpatient & ACT   
Office Hours: 1st, 2nd & 3rd Thur  County: Meagher  
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 Boyd Andrew Community Services 
Jefferson County Alcohol Services  
102 N Brooke St  
P.O. Box 1156  
Whitehall MT 59759  
Ron Napierala  222  
 Phone 1: (406) 287-3219  Email: 
rnapierala@boydandrew.com 
Email 2:  
Phone 2: (406) 443-2343  
Fax:  
Crisis Phone:  Website: 
www.boydandew.com  
  Services: Outpatient & ACT  
 Office Hours: Tuesday, 9:00 a.m. - 12:00 p.m.  County: Jefferson  
 
 
EMCMHC - Substance Abuse/Dependency 
Svcs  
Wolf Point Satellite Office  
Roosevelt County Courthouse  
Wolf Point MT 59201-0328  
Deborah Knox  273  
Email:  Phone 1: (406) 653-1872  
Email 2:  Phone 2:  
Website:  Fax:  
Crisis Phone:  
Services: Outpatient & ACT   
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SENATE, No. 494 
STATE OF NEW JERSEY 
212th LEGISLATURE 
PRE-FILED FOR INTRODUCTION IN THE 2006 SESSION  
Sponsored by: 
Senator NIA H. GILL 
District 34 (Essex and Passaic) 
Senator WILLIAM L. GORMLEY 
District 2 (Atlantic) 
Co-Sponsored by: 
Senators Vitale, Weinberg and Karcher 
SYNOPSIS 
     "Bloodborne Disease Harm Reduction Act"; permits establishment of sterile syringe 
access programs.  
CURRENT VERSION OF TEXT  
     Introduced Pending Technical Review by Legislative Counsel 
AN ACT providing for sterile syringe access programs, supplementing Title 26 of the 
Revised Statutes and Title 2C of the New Jersey Statutes and amending P.L.1989, c.34. 
     BE IT ENACTED by the Senate and General Assembly of the State of New Jersey: 
     1.  (New section)  This act shall be known and may be cited as the  "Bloodborne 
Disease Harm Reduction Act." 
     2.  (New section)  The Legislature finds and declares that: 
     a.  New Jersey, in comparison with other states nationwide, has the highest rate of 
HIV infection among women, the third highest pediatric HIV rate, the fifth highest adult 
HIV rate, and a rate of injection-related HIV infection that is almost twice the national 
average; 
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     b.  About one in every three persons living with HIV or AIDS is female; 
     c.  Sterile syringe access programs have been proven effective in reducing the spread 
of HIV, hepatitis C and other bloodborne pathogens without increasing drug abuse or 
other adverse social impacts; yet New Jersey remains one of only two states nationwide 
that provide no access to sterile syringes in order to prevent the spread of disease; 
     d.  Every scientific, medical and professional agency or organization that has studied 
this issue, including the federal Centers for Disease Control and Prevention, the 
American Medical Association, the American Public Health Association, the National 
Academy of Sciences, the National Institutes of Health Consensus Panel, the American 
Academy of Pediatrics, and the United States Conference of Mayors, has found sterile 
syringe access programs to be effective in reducing the transmission of HIV; and 
     e.  Sterile syringe access programs are designed to prevent the spread of HIV, hepatitis 
C and other bloodborne pathogens, and to provide a bridge to drug abuse treatment and 
other social services for drug users; and it is in the public interest to encourage the 
development of such programs in this State in accordance with statutory guidelines 
designed to ensure the safety of consumers who use these programs, the health care 
workers who operate them, and the members of the general public. 
     3.  (New section)  The Commissioner of Health and Senior Services shall prescribe by 
regulation requirements for a municipality to establish, or otherwise authorize the 
operation within that municipality of, a sterile syringe access program to provide for the 
exchange of hypodermic syringes and needles in accordance with the provisions of this 
act. 
     a.  The commissioner shall: 
     (1)  request an application, to be submitted on a form and in a manner to be prescribed 
by the commissioner, from any municipality that seeks to establish a sterile syringe 
access program, or from other entities authorized to operate a sterile syringe access 
program within that municipality as provided in paragraph (2) of subsection a. of section 
4 of this act; 
     (2)  approve those applications that meet the requirements established by regulation of 
the commissioner and contract with the municipalities or entities whose applications are 
approved to establish a sterile syringe access program as provided in paragraph (2) of 
subsection a. of section 4 of this act to operate a sterile syringe access program in any 
municipality in which the governing body has authorized the operation of sterile syringe 
access programs within that municipality by ordinance; 
     (3)  support and facilitate, to the maximum extent practicable, the linkage of sterile 
syringe access programs to such health care facilities and programs as may provide 
appropriate health care services, including mental health and substance abuse treatment, 
to consumers participating in any such program; 
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     (4)  provide for the adoption of a uniform identification card or other uniform 
Statewide means of identification for consumers, staff and volunteers of a sterile syringe 
access program pursuant to paragraph (8) of subsection b. of section 4 of this act; and 
     (5)  maintain a record of the data reported to the commissioner by sterile syringe 
access programs pursuant to paragraph (10) of subsection b. of section 4 of this act. 
     b.  The commissioner shall be authorized to accept such funding as may be made 
available from the private sector to effectuate the purposes of this act. 
     4.  (New section)  a.  In accordance with the provisions of section 3 of this act, a 
municipality may establish or authorize establishment of a sterile syringe access program 
that is approved by the commissioner to provide for the exchange of hypodermic syringes 
and needles. 
     (1)  A municipality that establishes a sterile syringe access program may operate the 
program directly or contract with one or more of the following entities to operate the 
program: a hospital or other health care facility licensed pursuant to P.L.1971, c.136 
(C.26:2H-1 et seq.), a federally qualified health center, a public health agency, a 
substance abuse treatment program, an AIDS service organization, or another nonprofit 
entity designated by the municipality.  These entities shall also be authorized to contract 
directly with the commissioner in any municipality in which the governing body has 
authorized the operation of sterile syringe access programs by ordinance pursuant to 
paragraph (2) of this subsection. 
     (2)  Pursuant to paragraph (2) of subsection a. of section 3 of this act, a municipality 
whose governing body has authorized the operation of sterile syringe access programs 
within the municipality may require within the authorizing ordinance that an entity as 
described in paragraph (1) of this subsection obtain approval from the municipality, in a 
manner prescribed by the authorizing ordinance, to operate a sterile syringe access 
program prior to obtaining approval from the commissioner to operate such a program, or 
may permit the entity to obtain approval to operate such a program by application directly 
to the commissioner without obtaining prior approval from the municipality. 
     (3)  Two or more municipalities may jointly establish or authorize establishment of a 
sterile syringe access program that operates within those municipalities pursuant to 
adoption of an ordinance by each participating municipality pursuant to this section. 
     b.  A sterile syringe access program shall comply with the following requirements: 
     (1)  Sterile syringes and needles shall be provided at no cost to consumers 18 years of 
age and older;  
     (2)  Program staff shall be trained and regularly supervised in:  harm reduction; 
substance abuse, medical and social service referrals; and infection control procedures, 
including universal precautions and needle stick injury protocol; and programs shall 
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maintain records of staff and volunteer training and of hepatitis C and tuberculosis 
screening provided to volunteers and staff; 
     (3)  The program shall offer information about HIV, hepatitis C and other bloodborne 
pathogens and prevention materials at no cost to consumers, and shall seek to educate all 
consumers about safe and proper disposal of needles and syringes; 
     (4)  The program shall provide information and referrals to consumers, including HIV 
testing options, access to substance abuse treatment programs, and available health and 
social service options relevant to the consumer's needs; 
     (5)  The program shall screen out consumers under 18 years of age from access to 
syringes and needles, and shall refer them to substance abuse treatment and other 
appropriate programs for youth; 
     (6)  The program shall develop a plan for the handling and disposal of used syringes 
and needles in accordance with requirements set forth at N.J.A.C.7:26-3A.1 et seq. for 
regulated medical waste disposal pursuant to the "Comprehensive Regulated Medical 
Waste Management Act," P.L.1989, c.34 (C.13:1E-48.1 et al.), and shall also develop and 
maintain protocols for post-exposure treatment; 
     (7)  The program shall maintain the confidentiality of consumers by the use of 
confidential identifiers, which shall consist of the first two letters of the first name of the 
consumer's mother and the two-digit day of birth and two-digit year of birth of the 
consumer, or by the use of such other uniform Statewide mechanism as may be approved 
by the commissioner for this purpose; 
     (8)  The program shall provide a uniform identification card that has been approved by 
the commissioner to consumers and to staff and volunteers involved in transporting, 
exchanging or possessing syringes and needles, or shall provide for such other uniform 
Statewide means of identification as may be approved by the commissioner for this 
purpose; 
     (9)  The program shall provide consumers at the time of enrollment with a schedule of 
program operation hours and locations, in addition to information about prevention and 
harm reduction and substance abuse treatment services; and 
     (10)  The program shall provide aggregate data on a quarterly basis to the 
commissioner, on a form and in a manner determined by the commissioner, that 
includes:  the number of consumers served by the program, the number of syringes and 
needles distributed each month, and the number and type of referrals provided to 
consumers.  
     c. A municipality may terminate a sterile syringe access program established or 
authorized pursuant to this act, which is operating within that municipality, if its 
governing body approves such an action by ordinance, in which case the municipality 
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shall notify the commissioner of its action in a manner prescribed by regulation of the 
commissioner. 
     5.  (New section)  a.  The Commissioner of Health and Senior Services shall report to 
the Governor and the Legislature, no later than one year after the effective date of this act 
and biannually thereafter, on the status of sterile syringe access programs established 
pursuant to sections 3 and 4 of P.L.     , c.    (C.     ) (pending before the Legislature as 
this bill), and shall include in that report the data provided to the commissioner by each 
sterile syringe access program pursuant to paragraph (10) of subsection b. of section  4 of 
P.L.     , c.    (C.     )(pending before the Legislature as this bill). 
     b.  The commissioner shall report to the Governor and the Legislature no later than six 
months after the date that the initial sterile syringe access program, which is approved by 
the commissioner pursuant to section 3 of P.L.     , c.    (C.     )(pending before the 
Legislature as this bill), commences its operations, and shall include in that report: 
     (1)  an assessment of whether an adequate number of substance abuse treatment 
program slots is available to meet the treatment needs of persons who have been referred 
to substance abuse treatment programs by sterile syringe access programs pursuant to 
paragraph (4) of subsection b. of section 4 of P.L.     , c.    (C.     ) (pending before the 
Legislature as this bill); and 
     (2) a recommendation for such appropriation as the commissioner determines 
necessary to ensure the provision of an adequate number of substance abuse treatment 
program slots for those persons. 
     6.  (New section)  a.  The Commissioner of Health and Senior Services, in 
consultation with the Commissioner of Environmental Protection and pursuant to the 
"Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt rules 
and regulations to effectuate the purposes of sections 3 and  4 of P.L.       , c.       (C.     
)(pending before the Legislature as this bill). 
     b.  Notwithstanding any provision of P.L.1968, c.410 to the contrary, the 
commissioner shall adopt, immediately upon filing with the Office of Administrative 
Law and no later than the 90th day after the effective date of this act, such regulations as 
the commissioner deems necessary to implement the provisions of sections 3 and 4 of 
P.L.     , c.    (C.     )(pending before the Legislature as this bill), which shall be effective 
until the adoption of rules and regulations pursuant to subsection a. of this section and 
may be amended, adopted or readopted by the commissioner in accordance with the 
requirements of P.L.1968, c.410. 
     7.  (New section)  The possession of a hypodermic syringe or needle by a consumer 
who participates in, or an employee or volunteer of, a sterile syringe access program 
established pursuant to sections 3 and 4 of P.L.  , c.   (C.   )(pending before the 
Legislature as this bill) shall not constitute an offense pursuant to N.J.S.2C:36-1 et seq.  
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This provision shall extend to a hypodermic syringe or needle that contains a residual 
amount of a controlled dangerous substance or controlled substance analog. 
     8.  Section 3 of P.L.1989, c.34 (C.13:1E-48.3) is amended to read as follows: 
     3.  As used in sections 1 through 25 of this act: 
     "Board" means the Board of Public Utilities. 
     "Collection" means the activity related to pick-up and transportation of regulated 
medical waste from a generator, or from an intermediate location, to a facility, or to a site 
outside the State, for disposal. 
     "Commissioners" means the Commissioner of Environmental Protection and the 
Commissioner of Health and Senior Services. 
     "Departments" means the Department of Environmental Protection and the 
Department of Health and Senior Services. 
     "Dispose" or "disposal" means the storage, treatment, utilization, processing, resource 
recovery of, or the discharge, deposit, injection, dumping, spilling, leaking, or placing of 
any regulated medical waste into or on any land or water so that the regulated medical 
waste or any constituent thereof may enter the environment or be emitted into the air or 
discharged into any waters, including groundwaters. 
     "Facility" means a solid waste facility as defined in section  3 of P.L.1970, c.39 
(C.13:1E-3); or any other incinerator or commercial or noncommercial regulated medical 
waste disposal facility in this State that accepts regulated medical waste for disposal. 
     "Federal Act" means the "Medical Waste  Tracking Act of 1988" (42U.S.C. s.6903 et 
seq.), or any rule or regulation adopted pursuant thereto. 
     "Generator" means an ambulatory surgical or care facility, community health center, 
medical doctor's office, dentist's office, podiatrist's office, home health care agency, 
health care facility, hospital, medical clinic, morgue, nursing home, urgent care center, 
sterile syringe access program operating pursuant to sections 3 and 4 of P.L.  , c.   (C.   
)(pending before the Legislature as this bill), veterinary office or clinic, animal, 
biological, clinical, medical, microbiological, or pathological diagnostic or research 
laboratory, any of which generates regulated medical waste, or any other facility 
identified by the departments that generates regulated medical waste. "Generator" shall 
not include individual households utilizing home self-care. 
     "Regulated medical waste" means blood vials; cultures and stocks of infectious agents 
and associated biologicals, including cultures from medical and pathological laboratories, 
cultures and stocks of infectious agents from research and industrial laboratories, wastes 
from the production of biologicals, discarded live and attenuated vaccines, and culture 
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dishes and devices used to transfer, inoculate, and mix cultures; pathological wastes, 
including tissues, organs, and body parts that are removed during surgery or autopsy; 
waste human blood and products of blood, including serum, plasma, and other blood 
components; sharps that have been used in patient care or in medical, research, or 
industrial laboratories engaged in medical research, testing, or analysis of diseases 
affecting the human body, including hypodermic needles, syringes, Pasteur pipettes, 
broken glass, and scalpel blades; contaminated animal carcasses, body parts, and bedding 
of animals that were exposed to infectious agents during research, production of 
biologicals, or testing of pharmaceuticals; any other substance or material related to the 
transmission of disease as may be deemed appropriate by the departments; and any other 
substance or material as may be required to be regulated by, or permitted to be exempted 
from, the Federal Act.  The departments may adopt, by rule or regulation and pursuant to 
the  "Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), a more 
specific definition of regulated medical waste upon the expiration of the demonstration 
program established under the Federal Act. 
     "Noncommercial facility" means a facility or on-site generator, as the case may be, 
which accepts regulated medical waste from other generators for on-site disposal for a 
cost-based fee not in excess of the costs actually incurred by the facility or on-site 
generator for the treatment or disposal of the regulated medical waste. 
     "Transporter" means a person engaged in the collection or transportation of regulated 
medical waste. 
(cf:  P.L.1989, c.34, s.3)  
     9.  (New section)  a.  The board of chosen freeholders of each county and the New 
Jersey Meadowlands Commission, in accordance with standards adopted by the 
Commissioner of Environmental Protection in consultation with the Commissioner of 
Health and Senior Services, shall prepare and adopt a sharps disposal component as an 
amendment to the district solid waste management plan required pursuant to the 
provisions of the "Solid Waste Management Act," P.L.1970, c.39 (C.13:1E-1 et seq.) to 
provide for the proper and safe disposal of medical waste generated at home within the 
district.  
     b.  The sharps disposal component of each district solid waste management plan shall 
be developed in consultation with a work group established by the governing body of the 
affected county and the New Jersey Meadowlands Commission, in the case of the 
Hackensack Meadowlands District, that includes persons not employed by or affiliated 
with the county or the commission, as the case may be, who have a demonstrated interest 
or expertise in the use and disposal of sharps, including, but not limited to, 
representatives of waste management companies, persons with diabetes and licensed 
health care facilities. 
     c.  The Commissioner of Environment Protection shall provide such financial 
assistance as may be available to the commissioner for the purpose of this section to the 
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various counties to implement the sharps disposal component of the district solid waste 
management plan.  The commissioner shall be authorized to accept such funding as may 
be made available from the private sector to effectuate the purposes of this section. 
     10.  (New section)  a.  The Commissioner of Environmental Protection, in 
consultation with the Commissioner of Health and Senior Services and pursuant to the 
"Administrative Procedure Act," P.L.1968, c.410 (C.52:14B-1 et seq.), shall adopt rules 
and regulations to effectuate the purposes of section 9 of P.L.     , c.    (C.    ) (pending 
before the Legislature as this bill). 
     b.  Notwithstanding any provision of P.L.1968, c.410 to the contrary, the 
commissioner shall adopt, immediately upon filing with the Office of Administrative 
Law and no later than the 90th day after the effective date of this act, such regulations as 
the commissioner deems necessary to implement the provisions of section 9 of P.L.     , 
c.    (C.     )(pending before the Legislature as this bill), which shall be effective until the 
adoption of rules and regulations pursuant to subsection a. of this section and may be 
amended, adopted or readopted by the commissioner in accordance with the requirements 
of P.L.1968, c.410. 
     11.  This act shall take effect immediately. 
 
STATEMENT 
     This bill, which is designated the "Bloodborne Disease Harm Reduction Act," permits 
the establishment of sterile syringe access programs to prevent the spread of HIV/AIDS, 
hepatitis C and other bloodborne diseases. 
     Specifically, the bill provides as follows: 
     --  The Commissioner of Health and Senior Services is directed to prescribe by 
regulation requirements for a municipality to establish, or otherwise authorize the 
operation within that municipality of, a sterile syringe access program to provide for the 
exchange of hypodermic syringes and needles.  
     --  The commissioner is to: 
     (1)  request an application, to be submitted on a form and in a manner to be prescribed 
by the commissioner, from any municipality that seeks to establish a sterile syringe 
access program, or from other entities authorized to operate a sterile syringe access 
program within that municipality as provided in the bill;  
     (2)  approve those applications that meet the requirements established by regulation of 
the commissioner and contract with the municipalities or entities whose applications are 
approved to establish a sterile syringe access program as provided in the bill to operate a 
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sterile syringe access program in any municipality in which the governing body has 
authorized the operation of sterile syringe access programs within that municipality by 
ordinance; 
     (3)  support and facilitate, to the maximum extent practicable, the linkage of sterile 
syringe access programs to such health care facilities and programs as may provide 
appropriate health care services, including mental health and substance abuse treatment, 
to consumers participating in any such program; 
     (4)  provide for the adoption of a uniform identification card or other uniform 
Statewide means of identification for consumers, staff and volunteers of a sterile syringe 
access program; and 
     (5)  maintain a record of the data reported to the commissioner by sterile syringe 
access programs pursuant to the bill. 
     --  The commissioner is authorized to accept such funding as may be made available 
from the private sector to effectuate the purposes of the bill. 
     --  A municipality may establish or authorize establishment of a sterile syringe access 
program that is approved by the commissioner pursuant to the bill to provide for the 
exchange of hypodermic syringes and needles. 
     (1)  A municipality that establishes a sterile syringe access program may operate the 
program directly or contract with one or more of the following entities to operate the 
program: a hospital or other licensed health care facility, a federally qualified health 
center, a public health agency, a substance abuse treatment program, an AIDS service 
organization, or another nonprofit entity designated by the municipality.  These entities 
will also be authorized to contract directly with the commissioner in any municipality in 
which the governing body has authorized the operation of sterile syringe access programs 
by ordinance pursuant to the bill. 
     (2)  A municipality whose governing body has authorized the operation of sterile 
syringe access programs within the municipality may require within the authorizing 
ordinance that an entity as described in the bill obtain approval from the municipality, in 
a manner prescribed by the authorizing ordinance, to operate a sterile syringe access 
program prior to obtaining approval from the commissioner to operate such a program, or 
may permit the entity to obtain approval to operate such a program by application directly 
to the commissioner without obtaining prior approval from the municipality to operate 
such a program. 
     (3)  Two or more municipalities may jointly establish or authorize establishment of a 
sterile syringe access program that operates within those municipalities pursuant to 
adoption of an ordinance by each participating municipality. 
     --  A sterile syringe access program must comply with the following requirements: 
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     (1)  Sterile syringes and needles are to be provided at no cost to consumers 18 years of 
age and older; 
     (2)  Program staff are to be trained and regularly supervised in:  harm reduction; 
substance abuse, medical and social service referrals; and infection control procedures, 
including universal precautions and needle stick injury protocol; and programs are to 
maintain records of staff and volunteer training and of hepatitis C and tuberculosis 
screening provided to volunteers and staff; 
     (3)  The program is to offer information about HIV, hepatitis C and other bloodborne 
pathogens and prevention materials at no cost to consumers, and seek to educate all 
consumers about safe and proper disposal of needles and syringes; 
     (4)  The program is to provide information and referrals to consumers, including HIV 
testing options, access to substance abuse treatment programs, and available health and 
social service options relevant to the consumer's needs; 
     (5)  The program is to screen out consumers under 18 years of age from access to 
syringes and needles, and refer them to substance abuse treatment and other appropriate 
programs for youth; 
     (6)  The program is to develop a plan for the handling and disposal of used syringes 
and needles in accordance with requirements set forth at N.J.A.C.7:26-3A.1 et seq. for 
regulated medical waste disposal pursuant to the "Comprehensive Regulated Medical 
Waste Management Act," and also develop and maintain protocols for post-exposure 
treatment; 
     (7)  The program is to maintain the confidentiality of consumers by the use of 
confidential identifiers, which are to consist of the first two letters of the first name of the 
consumer's mother and the two-digit day of birth and two-digit year of birth of the 
consumer, or by the use of such other uniform Statewide mechanism as may be approved 
by the commissioner for this purpose; 
     (8)  The program is to provide a uniform identification card that has been approved by 
the commissioner to consumers and to staff and volunteers involved in transporting, 
exchanging or possessing syringes and needles, or provide for such other uniform 
Statewide means of identification as may be approved by the commissioner for this 
purpose; 
     (9)  The program is to provide consumers at the time of enrollment with a schedule of 
program operation hours and locations, in addition to information about prevention and 
harm reduction and substance abuse treatment services; and 
     (10)  The program is to provide aggregate data on a quarterly basis to the 
commissioner, on a form and in a manner determined by the commissioner, that 
includes:  the number of consumers served by the program, the number of syringes and 
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needles distributed each month, and the number and type of referrals provided to 
consumers. 
     --  c.  A municipality may terminate a sterile syringe access program established or 
authorized pursuant to the bill, which is operating within that municipality, if its 
governing body approves such an action by ordinance, in which case the municipality is 
to notify the commissioner of its action in a manner prescribed by regulation of the 
commissioner. 
     --  The Commissioner of Health and Senior Services is directed to report to the 
Governor and the Legislature, no later than one year after the effective date of the bill and 
biannually thereafter, on the status of sterile syringe access programs established pursuant 
to the bill, and is to include in that report the data provided to the commissioner by each 
sterile syringe access program pursuant to the bill. 
     --  The commissioner is further directed to report to the Governor and the Legislature 
no later than six months after the date that the initial sterile syringe access program, 
which is approved by the commissioner pursuant to the bill, commences its operations, 
and is to include in that report: 
     (1)  an assessment of whether an adequate number of substance abuse treatment 
program slots is available to meet the treatment needs of persons who have been referred 
to substance abuse treatment programs by sterile syringe access programs pursuant to the 
bill; and 
     (2)  a recommendation for such appropriation as the commissioner determines 
necessary to ensure the provision of an adequate number of substance abuse treatment 
program slots for those persons. 
     --  The possession of a hypodermic syringe or needle by a consumer who participates 
in, or an employee or volunteer of, a sterile syringe access program established pursuant 
to the bill will not constitute an offense pursuant to N.J.S.A.2C:36-1 et seq.  This 
provision extends to a hypodermic syringe or needle that contains a residual amount of a 
controlled dangerous substance or controlled substance analog. 
     --  Each county freeholder board and the New Jersey Meadowlands Commission, in 
accordance with standards adopted by regulation of the Commissioner of Environmental 
Protection in consultation with the Commissioner of Health and Senior Services, is to 
prepare and adopt a sharps disposal component as an amendment to the district solid 
waste management plan required pursuant to the "Solid Waste Management Act" to 
provide for the proper and safe disposal of medical waste generated at home within the 
district. 
     (1)  The sharps disposal component of each district solid waste management plan is to 
be developed in consultation with a work group established by the governing body of the 
affected county and the New Jersey Meadowlands Commission, in the case of the 
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Hackensack Meadowlands District, that includes persons not employed by or affiliated 
with the county or the commission, as the case may be, who have a demonstrated interest 
or expertise in the use and disposal of sharps, including, but not limited to, 
representatives of waste management companies, persons with diabetes and licensed 
health care facilities. 
     (2)  The Commissioner of Environmental Protection is to provide such financial 
assistance as may be available to the commissioner to the various counties to implement 
the sharps disposal component of the district solid waste management plan, and is 
authorized to accept such funding as may be made available from the private sector for 
this purpose. 
     --  The bill directs the Commissioners of Health and Senior Services and 
Environmental Protection to adopt rules and regulations, pursuant to the "Administrative 
Procedure Act" (APA), to effectuate the purposes of the bill; however, notwithstanding 
any provision of the APA to the contrary, the commissioners are to adopt, immediately 
upon filing with the Office of Administrative Law and no later than the 90th day after the 
effective date of the bill, such regulations as they deem necessary to implement the bill, 
which are to be effective until the adoption of rules and regulations pursuant to the APA 
and may be amended, adopted or readopted by the commissioners in accordance with the 
APA.  (It is the sponsors' intent that the Commissioner of Health and Senior Services 
may consult with the Public Health Council established pursuant to N.J.S.A.26:1A-4 in 
the adoption of rules and regulations to effectuate the purposes of the bill.) 
     It is the opinion of the sponsors that a municipality which establishes or authorizes a 
sterile syringe access program pursuant to this bill and its employees would be covered 
by the provisions of N.J.S.A.59:6-3, which provides as follows: "Neither a public entity 
nor a public employee is liable for an injury resulting from the decision to perform or not 
to perform any act to promote the public health of the community by preventing disease 
or controlling the communication of disease within the community." 
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